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Abstract 
In the last years, gold and iron oxide nanoparticles have received an increasing 
interest in nanomedicine and biotechnology thanks to their properties. Gold 
nanoparticles (AuNPs) are biocompatible and possess useful optical properties that 
make them a powerful imaging tool using, for example, SERS spectroscopy. On the 
other hand, iron oxide nanoparticles (FeOxNPs, in particular those made of 
magnetite) are interesting because of their magnetic properties. Combining gold and 
iron oxide nanoparticles in a unique system, one obtains a magneto-plasmonic 
material in which the characteristics properties of the two nanoparticles are present. 
The use of magneto-plasmonic nanostructured materials in nanomedicine is a quite 
young research topic and one of the reasons is the elaborated synthesis often 
required. Several passages are needed also for the purification of these nanosystem 
from chemicals used during synthesis, which is a crucial point when the final 
application is in nanomedicine or nanobiology. In this work we will show the 
synthesis of two magneto-plasmonic systems made of gold and iron oxide 
nanoparticles. AuNPs and FeOxNPs are synthetized with the laser ablation synthesis 
in solution (LASiS) method. LASiS is a green chemistry method, which allows to 
obtain chemical-free and stable nanoparticles in water solution. With LASiS, 
purification passages are unnecessary or reduced to a minimum and no chemicals 
that could interfere in biological environment are present. In chapter 2 it will be 
reported the synthesis of gold and iron oxide nanoclusters (AuFeOxNC) in which the 
aggregation between particles is performed without the use of chemicals, but 
exploiting the surface charges of nanoparticles. The use of such nanoclusters in cells 
guiding and sorting and imaging will be also shown. 
In chapter 3, the synthesis of another magneto-plasmonic system in which AuNPs 
and FeOxNPs are arranged in a core-shell-satellite structure, is reported. Also in this 
case, purification passages are reduced thanks to the laser ablation synthesis. This 
system is conjugated with an antibody and shows high performance in 
immunomagnetic sorting and photothermal treatment of cancer cells. 
The arguments developed in the thesis are introduced in the first chapter.  
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An introduction to nanotechnology 
The word “nanotechnology” is nowadays being listened and read more and more 
often also in non-specialist sources like, for example, newspaper, television news and 
in all that journals that write about science for a non-scientist audience. For a layman 
it could be difficult to visualize the “nano” dimension; however the interest for this 
branch of science is clearly present for the perspectives that can be perceived.  
The concept of manipulating atoms at the nanoscale was first introduced by Richard 
Feynman in 1959 in his lecture “There’s plenty of a room at the bottom”1 in which 
he described the possibility of synthesis directly manipulating atoms. However, the 
term “nanotechnology” was first used by a Japanese scientist called Norio Taniguchi 
in a conference2, to describe semiconductor processes such as thin film deposition 
and ion beam milling with a control of the order of nanometer. The term was later 
used by K. Eric Drexler which, inspired by Feynman, proposed the idea of a 
nanoscale assembler able to replicate itself with atomic precision in his book 
“Engines of Creation: The Coming Era of Nanotechnology”.3 Nanotechnology had a 
bootstrap in 1981 with the invention of the scanning tunneling microscope (STM) by 
Gerd Binning and Heinrich Rohrer at IBM Zurich Research Laboratory.4,5 STM, 
which is based on the concept of quantum tunneling, can be used for imaging of 
surfaces with atomic resolution and also to manipulate atoms: in 1989 Don Eigler 
and co-workers at the IBM Research Lab in Almaden, California, used an STM to 
write the IBM logo with 35 xenon atoms on a nickel surface (Figure 1.1).6 
 
Figure 1.1 IBM logo wrote using a STM microscope. 
 
Thanks to advances in technology it was possible to observe the nano dimension and 
to control it. 
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Few years later these advances in technology leads to the discovery of fullerenes 
(C60) and carbon nanotubes, new promises for semiconductor science.7  
Although it seems nanotechnology has its first development in ‘80s, scientists (and 
not only scientists) have been dealing with nanomaterials long time before, for 
example when scientific studies, like those of Faraday on colloidal solutions, were 
conducted in the XIX century. 
Nanoparticles 
Nanoparticles (NPs) are objects with nanometric size, usually in the range of 1-100 
nm. At the beginnings they weren’t associated to nanotechnology because they were 
studied in an interdisciplinary science between physics and chemistry called interface 
and colloids science (which includes also particles of dimensions up to 1000 nm). 
NPs have a long history, in particular those made of gold and silver because of the 
most attractive properties among all metal nanoparticles. Gold nanoparticles 
(AuNPs) are found in the 4-th century Lycurgus cup in which they affect the color of 
the glass depending on the location of the light source.8 Gold, silver and copper 
nanoparticles were often used in glazes or glasses to obtain different colors since 
bronze ages.9 In middle ages, AuNPs solutions were believed to have curative 
properties to various diseases. In 1618 Francisci Antonii, philosopher and member of 
medical profession, wrote a book entitled “Panacea Aurea, sive tractatus duo de 
ipsius Auro Potabili” (“Gold potion, or two treatments of potable gold”).10 The first 
to provide a scientific description of gold nanoparticles was Michael Faraday in 
1850s: in 1857 he prepared the first pure sample of colloidal gold reducing gold 
chloride with phosphorus and, subsequently, he recognized that the typical ruby red 
color of AuNPs was due to the reduced size of gold.11 Apart from Faraday other 
pioneering studies on gold nanoparticles were conducted by R.A. Zsigmondy, who 
coined the term “nanometer” for characterize particle size12 and Gustav Mie, who 
provided the theory for scattering and absorption by spherical particles.13 Research 
on nanoparticles accelerated in the first decades of ‘900 with advances in technology, 
as happened with nanotechnology, in particular with the development of electron 
microscopy and atomic force microscopy. Although AuNPs were and are the most 
studied type of NPs (thanks to their attractive properties and their easy synthesis), 
nowadays nanoparticles can be made of many different materials with many different 
methods and shape and they can be either suspended in solvents (generically called 
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colloidal solutions) or used in powder as well. They are interesting because chemical 
and physical properties of nanoparticles strongly depend on the material they are 
made and can differ a lot from those of the bulky material. For example, thank of 
their dimension, they have a high surface to volume ratio (1 kg of particles of 1 mm3 
has the same surface area as 1 mg of particles of 1 nm3) which make them suitable, 
for example, for uses in catalysis where a large accessible surface is preferred.14 
Applications of NPs in biological and medical fields are also very common thanks to 
their nanometric size, which makes possible to have, to control and to study direct 
interactions with tissues at subcell levels.14  
Engineering of the surface of nanoparticles is obviously a crucial point: how they 
interact with the environment depends on what is present on the surface and, clearly, 
the surface itself has properties that differ depending on the material. In this thesis 
we will focus on nanoparticles, in particular those made of gold and iron oxide, for 
biomedical application. So we will see why these two materials are important for this 
kind of applications, how they can interact with biological environment and how 
their surface can be engineered for new useful properties. Having different materials 
different properties and being possible to modify their surface, a lot of applications 
can be forseen. 
Nowadays nanoparticles gave a great boost to nanoscience and find applications in 
chemical industry15, pharmaceuticals, biotechnology, medicals16,17, microfluidics, 
semiconductors among others. 
 
Nanomedicine 
Since researches on nanoparticles began to establish, the understanding of their 
importance in biology and medicine was only a matter of time. In January 2000 the 
US president Bill Clinton announced an investment of $475 million on 
nanotechnology research development via the National Nanotechnology Initiative 
(NNI).18 Investments in NNI reached about $1500 million in 2014-2016 with a 30% 
for the Department of Health and Human Services (DHHS).19  
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Nanomedicine was a new field emerging from the interest of applying 
nanotechnology to medicine. The purpose is that of diagnoses, treating and 
preventing diseases and traumatic injury, relieving pain, improving and preserving 
human health using molecular tools and knowledge of the human body. 
The field of nanomedicine has been rapidly expanding since first years of 2000, 
Table 1.1 gives an idea of the many directions in which researches on nanomedicine 
are splitted.18 
 
Table 1.1 Application of nanotechnology to medicine led to the appearance of many 
topics of research.18 
 
In a very general way we can divide researches in nanomedicine in the following 
four topics: 
1. Nanomedicine applications for use inside the body: this include, for example, 
anticancer drugs, gene therapy or prostheses applications of nanotechnologic 
materials. 
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2. Nanomedicine applications for diagnostic techniques: some examples are 
nanoparticle biolabels, nanoscale visualization, biochips/microarrays, 
nanoproteomic-based diagnostics, nanoparticle-based nucleic acid 
diagnostics, nanoparticle-based immunoassays, DNA nanomachines, 
nanobiosensors, biobarcode assays, and nanopore technology.20 
3. Nanomedicine in drug based approaches: in this case nanostructured 
materials are used as vectors to deliver drugs specifically to damaged or 
unhealthy tissues.21-23 
4. Lab-on-a-chip techniques: here nanostructured materials can be used to build 
or to operate in small devices (that usually have the sizes of 
millimeters/centimeters) which incorporate numerous laboratory tasks. 
Healthcare services can use Lab-on-a-chip technology to check patients at 
point-of-care facilities or in remote or resource-poor locations, therefore 
reducing checking time from days to minutes.24 
There are five general steps in the development of nanomedicine (Figure 1.2). This 
means that although the literature is very extensive on this argument, due to the 
novelty of the field, nanomedicine products that are currently under clinical 
investigation or already commercialized are no more than a pair of hundreds. 
Most of these products are nanoparticles25 which we can divide in two main groups: 
1. Hard nanoparticles 
2. Soft nanoparticles 
Hard nanoparticles used in nanomedicine, as the name suggests, consists of gold, 
silver, iron oxide, ceramic and carbon. Soft nanoparticles, in contrast to hard NPs, 
includes liposomes, micelles, dendrimers, emulsions, protein and polymeric 
nanostructures.25 
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Figure 1.2 General steps in the development of nanomedicine. Approved or under 
clinical investigations products will have the strongest impact on the direction of 
nanomedicine. 25 
 
Table 1.2 provides an outlook on the type of nanostructures for nanomedicine 
products approved by FDA in diverse development status (investigational or 
commercial). It is interesting to notice the relevance of hard nanoparticles in 
commercial products and of soft nanoparticles (in particular liposomes) in 
investigational products. 
 
Table 1.2 Type of nanostructures for confirmed and likely nanomedicine 
applications and products, by development status.25 
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Applications of these nanomedicine products can be as therapeutics or as devices. 
The first one refers to products that intend to direct remedy a medical condition (i.e. 
cancer treatment, diseases and disorders of various types). Devices category includes 
for example products for in vitro testing, in vivo imaging, in vivo device coatings, 
medical dressing/textiles and others. 
Regarding therapeutics applications, most of nanomedicine products are for cancer 
treatment: in particular two-third of the investigational products are for cancer 
treatment while the number of approved commercial products are quite the same for 
each category (Figure 1.3A). Regarding their use as device, in vitro testing and in 
vivo imaging seems to be the more promising categories (Figure 1.3B). 
 
 
Figure 1.3 Medical uses for confirmed and likely therapeutics (A) and devices (B).25 
 
One of the most relevant biomedical characteristics of nanostructured materials are 
the unique biodistribution profiles they achieve once administered, which is not 
possible with conventional molecular or microscale delivery. Nanosystems can be 
appositely designed to target specific tissues or areas of the body. Confirmed and 
likely applications and products mainly focus on intravenous administration (73%, 
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Figure 1.4). After administration a nanosystem can behave in different manner 
depending of the sophistication of targeting, which is distinguished in passive or 
active. 
The passive targeting is used by those nanosystems which take advantage of the 
enhanced permeability and retention (EPR) effect, a size and geometry dependent 
mode of action. On the other side the active targeting uses mechanisms that are 
beyond the simple dependency by size and geometry to enhance preferential delivery 
to a specific tissue or area of the body. Usually active targeting nanostructures are 
functionalized with ligands (like antibodies) which bind to specific receptors. 
Anyway most of the nanomedicine confirmed, and likely intravenous-administered 
products, make use of the passive targeting (Figure 1.4).25 
 
Figure 1.4 Different routes of administration for confirmed and likely nanomedicine 
products. Most of intravenous-administered products make use of passive targeting.25 
 
To finish this brief overlook on nanomedicine it’s appropiate to make some 
observations on currently commercialized nanomedical products. 
Table 1.3 summarizes products that have been approved by FDA in last years. Most 
of these are nanoparticles. Hydroxapatite nanocrystals are used as bone substitutes, 
ceramic or silica nanoparticles find their use in dentistry, silver nanoparticles exploit 
their antimicrobial activity as device or dressing coatings. The thesis focuses in 
particular on gold or iron oxide nanoparticles based structures. As reported in table 
1.3, these nanoparticles are only used for in vitro assay applications. Magnetic 
nanoparticles (CellTrack®, CellSearch®) functionalized with an antibody are used to 
magnetically select cells (active targeting) with a technique called immunomagnetic 
sorting. On the other side, optical properties of antibody-labeled gold nanoparticles 
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(NicAlert, Verigene) are used for the detection of biomarkers. In this thesis we will 
see the possibility of combining both iron oxide and gold nanoparticles properties in 
a unique system. 
 
Table 1.3 List of nanomedicine products approved by FDA.25 
 
We will see the application in cancer cell treatment of a nanosystem composed by 
AuNPs and FeOxNPs. When a nanostructure, beyond active targeting, induce a 
mechanism of action beyond purely size dependent biological and chemical 
interactions it is said to have an “active behavior”. Confirmed and likely 
nanomedicine products that show this behavior are listed in table 1.4. 
 
 
Chapter 1 
14 
 
Table 1.4 Confirmed and likely nanomedicine products which show active behavior 
beyond active targeting.25 
 
In this case, most of the products are iron oxide nanoparticles: they are used as MRI 
contrast agents or in magnetothermia therapy which consists on killing targeted cells 
using heat that FeOxNPs generates when stimulated under an appropiate alternated 
magnetic field. Also gold nanoparticles exhibit this behavior when irradiated with an 
appropriate laser light. Surprisingly no drug-loaded nanoparticles are present in the 
list, meaning that there is much work to do under this aspect. 
Concluding, we can resume some relevant aspect of nanomedicine in the following 
points: 
• Most of nanomedicine products (currently approved or likely) are hard or soft 
nanoparticles 
• Most of the investigational nanomedicine therapeutics products are intended 
to be used in cancer treatment 
• Devices products are mostly designed to be used in in vitro testing or in vivo 
imaging 
• Passive targeting currently is the preferred targeting mechanism although 
active targeting is more specific and desirable 
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• Nanoparticles (in particular those made of iron oxides or gold) are 
commercialized and used as cancer hyperthermal treatment agents. 
Cancer nanotechnology 
Cancer is a major cause of mortality: only in US over 1.500.000 new cases are 
estimated in 2016 with almost 600.000 deaths.26 With these numbers it’s no wonder 
why nanomedicine is mostly concentering on cancer diagnosis and treatment. It is a 
highly complex disease which initially is localized but can spread in distant sites 
within the body becoming difficult to cure. Current diagnostics tools consists on 
radiology or histopathological examinations while most common treatments consists 
on chemotherapy, radiotherapy and, when possible, surgical removal.27 There are 
several drawbacks in using these therapies like non-specific distribution of drugs 
which lead to inadequate dose delivery to tumor site, high cytotoxicity, difficulties in 
monitoring therapeutic responses and possibility of the development of drug 
resistancy.28 However, as any other cancer therapy, the aim of cancer 
nanotechnology is to achieve the optimal drug concentration in tumor site in order to 
destroy cancer cells while leaving unaltered healthy cells or tissues. To overcome 
these problems several ligand-targeted therapeutic strategies have been developed 
like immunotoxins, radioimmunotherapeutics and drug immunoconjugates28 but 
limitiations in their delivery are still a problem. 
Nanosystems have four characteristics that distinguish them from other cancer 
therapeutics: 
1. They can themselves have a therapeutic or diagnostic function and can 
eventually carry a huge therapeutic payload. 
2. Nanosystems can be functionalized with targeting ligands (i.e. antibodies) 
ensuring high affinity and specificity for target cells. 
3. Can be designed to accommodate multiple drug molecules enabling 
combinatorial cancer therapy. 
4. Can bypass drug resistance mechanism and immunitary defense. 
Categories of nanosystems used in cancer nanotechnology with their principal uses 
are listed in table 1.5 and, as said before, they can act both with active or passive 
mechanism. 
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Categories Structure Uses References 
Liposomes Prospholipidic vescicles Drug delivery 29 
Nanoparticles Metallic (Au, FeOx 
etc.). Different shapes 
and dimensions. 
• Drug delivery 
• Imaging 
• Contrast agents 
• Hyperthermal 
treatment 
• Radiotherapy 
• Combined techniques 
• Diagnosis/Assay 
 
 
 
14,17,20,25,28,30-32
 
Polymeric micelles Micelles of amphiphilic 
surfactant molecules 
Drug delivery  
33,34
 
Dendrimers Macromolecular 
compounds with 
branches around an 
inner core 
• Drug delivery 
• Imaging 
• Contrast agents 
 
35
 
Nanocantilevers / 
Nanopillars 
Micro/nano array made 
of different materials 
Biomarker detection  
36
 
Carbon nanotubes Single or multi walled 
carbon nanotubes 
• Biomarker detection 
• Imaging 
• Hyperthermal 
treatment 
 
37
 
Quantum dots PbS, PbSe, CdSe, CdS, 
InS, InP (semiconductor 
nanoparticles) 
• Biolabels 
• Imaging 
 
38
 
Table 1.5 Categories of nanotechnologic materials with their principal uses in cancer 
research (adapted from reference28). 
 
Metallic nanoparticles seem to be promising tools in cancer treatment and diagnosis. 
This is due to their interesting chemical and physical properties which make them a 
very versatile tool. In particular, future directions of cancer nanotechnology are the 
development of theranostic nanosystems which, by definition, are able to 
simultaneously provide diagnosis and treatment of cancer. Gold and iron oxide 
nanoparticles possess very peculiar properties that make them a perfect theranostic 
tool either as separated entities or in a unique composite system. 
Gold nanoparticles in cancer research 
Gold nanoparticles possess very unique features that can’t be found in other metallic 
nanoparticles. First of all gold is known to be an almost chemically inert material and 
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for this reason is considered a biocompatible metal (either in bulk or nanoparticle 
form). Biologically speaking his biocompatibility derives from the fact that pure 
AuNPs does not release ions in solution which can bind to proteins or other 
biological entities thus affecting their function. This happen, for example, with silver 
nanoparticles: Ag ions can form complexes with biomolecules thus resulting in a 
toxic effect. For this reason AgNPs are commonly used as antimicrobial agents.39 In 
addition gold hardly oxidize, thus meaning a practically inexistent reactivity in 
biological water-based environments. 40,41 
Functionalization of the surface of gold nanoparticles is possible exploiting their 
affinity for sulphur or nitrogen. Molecules (polymers, drugs, dyes etc.) possessing 
thiols or amine groups are the most used to labels the surface of AuNP. In the same 
way bioconjugation with antibodies, DNA fragments, peptides etc. can be performed 
giving AuNP active targeting properties.14 
Optical properties of gold nanoparticles are used in cancer research for the 
development of imaging and diagnosis techniques. There are two ways to perform 
imaging or diagnosis using gold nanoparticles. The first consists in exploiting 
Surface Enhanced Raman Scattering (SERS), which consists on the enhancement of 
the Raman signal of a reporter molecule when it’s close to the surface of a gold 
nanoparticle. In this way, using a micro-Raman equipment, it is possible to track 
gold nanoparticles in cells or tissues. This technique is very sensitive (only few 
molecules on AuNP surface are necessary to obtain a clear signal) and allows 
multiplexed mode analysis, but is limited by the depth penetration of the laser 
used.31,42,43 The second way consists in labelling AuNP with fluorescent probes 
sufficiently distant from their surface (usually using a spacer molecule between the 
surface and the fluorescent probe) to avoid SERS effect and subsequent fluorescent 
quenching. Imaging is performed using a fluorescence microscope and is usually 
useful to track gold nanoparticles on tissues or cells. Clearly this technique is faster 
than SERS, at the present moment, but usually is very less sensitive and greater 
numbers of particle are needed to be visible.44 
Finally gold nanoparticles can also show active behavior beyond active targeting, 
becoming a complete theranostic tool. In this case there are three ways to perform 
cancer treatment using gold nanoparticles. First, gold nanoparticles can be loaded 
with drugs, which had to be released when the tumor site is reached. Assuming an 
efficient and selective targeting, the control of the release mechanism is a key issue. 
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Valid solutions consist in a release triggered by an external stimulus like a 
temperature change or pH variations. In this case AuNP are functionalized with 
polymers which change their conformation when a certain temperature or pH 
condition is reached. Before reaching the opportune condition the drug is entrapped 
in the polymeric matrix, but when conformation change the drug is released. pH 
responsive systems usually take advantage of the slightly acidic environment of 
tumor cells while temperature responsive systems are triggered using an external 
laser source which heat the nanoparticles.22,45,46 A second  strategy consists in 
radiotherapy enhanced by gold nanoparticles: loading high Z materials into the tumor 
could result in greater photoelectric absorption within the tumor than in surrounding 
tissues, and thereby the dose delivered to a tumor during radiation therapy is 
enhanced.28 
The third method for tumor treatment which does not include the use of drug is 
plasmonic photothermal therapy (PPT). When gold nanoparticles are irradiated with 
an appropriated laser sources, the light absorbed is converted into heat. Locally, the 
temperature that can be reached is sufficient to provoke cancer cell death. Usually, 
near infrared or infrared laser sources are preferred because their penetration depth is 
higher than visible lasers.44  
In this thesis gold nanoparticles will be used, in combination with iron oxide 
nanoparticles, for imaging technique, using the SERS effect, of cancer cells and then 
for treating cancer cells with PPT technique. 
Iron oxide nanoparticles in cancer research 
Iron oxide nanoparticles (FeOxNPs) are of particular interest in the field of 
nanomedicine and cancer research thanks to their magnetic properties.16,47 These 
nanoparticles are, most of the time, composed of magnetite (Fe3O4) but sometimes, 
depending on the synthesis, other iron oxides are found like maghemite (-Fe2O3) or 
both maghemite and magnetite. For this reason one usually refers to iron oxide 
nanoparticles as a general way to indicate these types of nanoparticles instead of 
specify the iron phase. 
Like gold nanoparticles, FeOxNPs show very low toxicity and this also encourages 
biomedical use of these NP. Functionalization of the surface is performed exploiting 
iron oxides affinity for molecules possessing carboxylates or phosphates groups. It’s 
also a common practice to cover iron oxide nanoparticles with a silica shell to 
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provide new functionalities or properties or simply to have different functional 
groups on the surface to perform other reactions. This is usually realized with a sol-
gel synthesis (Stöber synthesis).47 
FeOxNPs have four main uses in biomedical and carcer research: magnetic resonance 
imaging (MRI) contrast agents, in vitro bioseparation (immunomagnetic sorting), 
drug delivery and hyperthermia.47,48 
In MRI, the effect of relaxation times of iron nuclei on water protons is used to 
perform imaging of cells and tissues. Currently, several iron oxide nanoparticles 
formulations have been approved by Food and Drug Administration like Feridex, 
Endorem and Resovist.25 The use of FeOxNPs as MRI contrast agents instead of 
common gadolinium chelated complexes permits to overcome potential toxicity of 
these complexes. 
FDA approved MRI contrast agents like Endorem consists in non-targeting (without 
antibodies) superparamagnetic iron oxide nanoparticles which accumulate in normal 
lymph tissue after injection at tumor site. Since no accumulation takes place in 
metastatic nodes, lymphatic staging can be performed using MRI.49 
Future direction of FeOxNPs as MRI contrast agents involves the use of targeted 
nanoparticles so that they can specifically label tumor tissues or cells.48 
Another application of iron oxide nanoparticles in MRI is specific cell tracking. This 
consist in loading cells with a sufficient quantity of FeOxNPs (micromolar Fe 
concentration) and then track these cells in vivo by MRI. If a cell is sufficiently 
loaded with iron oxide nanoparticles MRI can provide cell tracking with a resolution 
approaching the size of a cell.47 
The second relevant application, which is important also for this project, is 
bioseparation. This consists in exploiting magnetic properties of FeOxNPs for an in 
vitro separation/purification of proteins or cells from other biological entities. In this 
case usually nanoparticles are functionalized with specific antibodies and the entire 
process is called immunoseparation or immunosorting. Bioseparation have several 
advantages in comparison with traditional separation procedures. For example all 
passages take place in one test tube, avoiding long and expensive chromatographic 
purifications. Another advantage of immunosorting is the possibility to concentrate 
biological samples in smaller volume. This is useful in rare cell separation, when 
cells that have to be detected are rare like in circulating tumor cells (CTC) 
detection.47,48,50-53 
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Regarding drug delivery, iron oxide nanoparticles utilizes the same release strategies 
as gold nanoparticles (temperature or pH release trigger) but the difference is that 
FeOxNPs accumulation to delivery site can be performed using external magnets.47,48 
Lastly, iron oxide nanoparticles can be used for therapeutic purposes in hyperthermia 
treatment. This time hyperthermia is not provoked by an adsorption of light, like in 
gold nanoparticles, but from the absorption of the energy of an oscillating magnetic 
field and conversion into heat. Heating is most due to relaxation process and 
hysteresis losses that transform energy into heat. Treatment is performed injecting 
iron oxide nanoparticles directly to tumor site and then thermoablation is performed 
using a RF emitter implanted in the interested area. Less intrusive method consists on 
irradiating the pathological area with an array of external microwave emitters. 47,48,54 
In this thesis project iron oxide nanoparticles will be used for cell guiding and 
immunosorting of specific cancer cells in combination with AuNP, thus exploiting 
their capacity of migrate in solution if exposed to a magnetic field gradient. 
Magneto-plasmonic nanoparticles in cancer research 
Magneto-plasmonic nanoparticles, as the name suggests, combine the magnetic 
properties of iron oxide nanoparticles with optical-plasmonic properties of gold 
nanoparticles. Magneto-plasmonic materials are not necessarily made only of gold 
and iron oxide. Other common studied materials are, for example, a combination of 
Ag (for plasmonics) and Co (for magnetics) substituting gold and iron oxide 
respectively.55,56  
However, gold and iron oxide nanoparticles are the most attractive magneto-
plasmonic materials for nanomedicine applications because of their biocompatibility 
and versatility, as recalled above. 
Combination of gold and iron oxide in a unique nanomaterial gives birth to a 
powerful tool for cancer research which makes possible to perform simultaneously 
diagnostic, imaging and treatment using combined techniques previously developed 
for the individual gold or iron oxide nanoparticles. 
The synthesis of these kinds of nanoparticles is rather complex and different 
morphologies or structures can be obtained (see “Common synthesis for magneto-
plasmonic materials” at pag 59). Also for this reason, currently, no commercial 
products with these characteristics are available, but they are one of the major 
focuses in nanomedicine because of the great potential of this type of nanostructures. 
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For example Urries et al. synthetized 100-200 nm diameter hollow and partially 
hollow nanoparticles with a magnetic core and gold shell which potentially can be 
used as theranostic agents.57 These nanoparticles proved to be useful as MRI contrast 
agents thanks to magnetite core and for NIR hyperthermia tool thanks to the gold 
shell. Furthermore, the cavity is capable to hosts small molecules like drugs for drug 
delivery options. 
Recently, from the group in which I developed this thesis it was reported the 
synthesis of gold and iron alloy nanoparticles (AuFeNPs) and their use as 
multimodal MRI-SERS and computed x-ray tomography (CT) imaging tool.58 These 
alloy nanoparticles showed good applicability in in vivo experiments and also an 
almost absent cytotoxicity. 
Bao et al synthetized hybrid iron oxide@gold core-shell nanoparticles for magnetic 
protein separation and purification. In this case gold surface is needed to take 
advantage of the easy functionalization with thiolated molecules.59 
Antibody functionalized Fe2O3@Au core-shell nanoparticles have been used for 
immunoseparation of antigens in solution with subsequent quantitative determination 
using a SERS assay.60 This time a free external gold surface served for SERS effect 
and as functionalization site. 
Since both gold and iron oxide nanoparticles can be utilized separately for 
photothermal and magnetothermal therapy, when they’re combined in a unique 
nanosystem the two techniques can be performed simultaneously. A very interesting 
example is found in a work of Espinosa and coworkers.61 They synthetized 
aggregates composed of a core with multiple iron oxide nanoparticles covered with a 
gold shell. After injection in an implanted tumor (mice) aggregates were stimulated 
simultaneously with an alternated magnetic field (110 kHz, 25 mT) and laser light 
(680 nm, 0.3 W cm-2) showing a doubled performance with respect to the two 
separated techniques. 
Other many valid examples of magneto-plasmonic nanoparticles for detection or 
treatment of cancer or pathogens are present in literature62-67, but only in few cases 
biologically active (antibody-labeled) magneto-plasmonic nanosystems were 
obtained.68-71 Furthermore, quantitative determination of the targeting activity of 
these systems is still absent or incomplete and more work is to be done before they 
reach the necessary quality for clinical trials. 
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Infographic in figure 1.5 provides a schematic summary of gold and iron oxide 
nanoparticles properties and applications of interest in cancer research. 
 
Figure 1.5. Infographic with properties and applications of interest in nanomedicine 
of gold and iron oxide nanoparticles.  
 
Magneto-plasmonic nanosystems made of gold and iron oxide nanoparticles are the 
object of this thesis, in particular their application in cell guiding, 
immunoseparation/imaging and photothermal treatment. 
Cancer: principal characteristics 
Cancer is characterized by an irregular growth of cells and the possibility of a 
diffusion of the same in other regions of the body.72 Tumor is a mass of cells, a 
visible expression of a formation process of neoplastic tissues that may have 
developed for years.73 It is though that cancer development is due to random 
succession of genetic mutations of DNA of cells that proliferate for many cycles and 
long periods.  
Unlikely healthy cells, tumor cells show an abnormal proliferation due to a lack in 
self-regulatory intracellular mechanisms and, frequently, also an abnormal 
angiogenesis affects involved tissues. Another important characteristic connected to 
tumors is the presence of so-called markers or biomarkers. These are substances, 
usually proteins, that can be found on blood or other corporal fluids and demonstrate 
the presence of the disease. Some of these markers have a concentration which is 
proportional to tumor mass and for this reason their monitoring is useful for 
diagnosis or to follow the progress of ongoing therapy.72 
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Cancer is diagnosed when the involved tissue is sufficiently diversified from 
surrounding cells. However there isn’t a unique diagnostic method and usually 
histological analysis is firstly performed, also with contrast agents that help 
recognition and detection of specific tumor cells (imaging techniques). 
On the contrary, benign tumors usually are similar to original tissues. They can 
develop and grow in any environment, but they are not invasive and keep separate 
from circumstantial tissues because of a connective tissue capsule that cover them. 
However problems can emerge when they become large enough to generate pressure 
in neighboring organs. 
On the other side, malignant tumor have two distinctive characteristics: cell 
abnormalities if compared to neighboring cells and the invasion of surrounding 
tissues. This last is the definitive proof when observing a malignant tumor in fact, in 
contrast with benign tumors, they’re not surrounded by a connective tissue capsule 
and they grow in a cluttered and disorganized way. Because of this, tumor cells can 
penetrate the lymphatic or circulatory system thus leading to the formation of 
tumoral mass in other parts of the body: the so-called metastasis.73 
Antibodies: structure and functions 
Antibodies (Ab), also called immunoglobulins (Ig), are glycoproteins with the 
function of localizing antigens and trigger a response from the immune system. They 
are synthetized by linfocite T cells and can either be expressed on cell surface or 
released in soluble form in the organism. 
Soluble antibodies act as immune system mediators binding to external antigens and 
triggering the immune system response.  
Thanks to their unique synthesis, immune system can, in theory, produce specific 
antibodies for every antigen. 
This feature makes antibodies a very interesting experimental, diagnostic and 
therapeutic tool. 
Antibodies have typical “Y” shape and are formed by four polypeptide chains equal 
two by two: two heavy chains and two light chains (Figure 1.6). 
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Figure 1.6 1. Fab region 2. Fc region 3. Heavy chain (blue) with one variable (VH) 
domain followed by a constant domain (CH1), a hinge region, and two more constant 
(CH2 and CH3) domains. 4. Light chain (green) with one variable (VL) and one 
constant (CL) domain 5. Complementarity determining region (CDR), antigen 
binding site (paratope) 6. Hinge regions.74 
 
The four polypeptide chains are bonded together through disulfide bridges. 
Light chains are formed by one variable (VL) and one constant (CL) domain while 
heavy chains are formed by a variable domain (VH), a hinge region and one or more 
constant domains (CH1, CH2, CH3…).  
Fragment antigen-binding (Fab) region is the most important site of the antibody 
because it’s responsible of antigen recognition and binding. It is composed of one 
constant and one variable domain from each heavy and light chain of the antibody. 
Every variable region of heavy and light chain contains three ipervariable regions or 
CDR (Complementarity determining regions). CDR portions determine the 
specificity to an antigen and most contributes to the bonding. 
The base of the Y with the rest of the two heavy chains is called Fragment 
crystallizable (Fc) and play a role in modulating immune cell activity. This region is 
responsible for the appropriate immune response to a given antigen, this by binding 
to specific receptors or complement proteins. 
There are two classes of antibody if referring to the production methods. 
Polyclonal antibodies (pAb) are produced by a population of different lymphocyte 
clones treated with the same antigen. Monoclonal antibodies (mAb) are obtained 
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from a population of the same lymphocyte clones so they will have the same 
specificity against one antigen.75 
Immune responses to tumors 
It’s a common opinion that immunity strengthening against tumors could be a 
promising approach to cancer therapy. 
One of the physiological functions of acquired immunity is the prevention of 
transformed cell growth and their destruction before they can generate a tumor mass. 
This phenomenon is called immune surveillance. 
Many experimental data corroborate the hypothesis that immune surveillance plays 
an important role in preventing tumor growth; however the fact that tumors develop 
also in perfectly healthy subjects from the immune point of view suggests that anti-
tumor response is quite weak, and easily overtaken by fast-growing tumors. 
As recalled above, malignancies express different types of molecules (biomarkers) 
that can be recognized as extraneous molecules by the immune system. If the 
immune system responds to a tumor, evidently, it expresses antigens that are 
recognized as non-self (extraneous). 
In experimental tumors, induced by carcinogenic chemical substances or radiations, 
antigens consist of mutant forms of normal protein cells. 
On the other hand, in many spontaneous human malignancies antigens that provoke 
an immune response seem to be perfectly normal proteins. The difference is that they 
are overexpressed or their expression, which is usually limited to particular tissues or 
stages of development, is deregulated. 
Although an immune response for self-normal antigens is not normally expected, 
their aberrant expression is sufficient to activate immune system. 
The principal mechanism by which the immune system acts against tumors is the 
killing of neoplastic cells by cytotoxic lymphocyte T cells (CTL) specific for tumoral 
antigens. Most of the time immune response can’t compete with such a fast 
neoplastic growth, also because a malignancy develops particular mechanisms to 
overcome immune response. For example, some neoplastic cells lose the expression 
of target antigens of the immune response: if such antigens are not essential for the 
maintenance of neoplastic phenotype, the tumor continues to grow and spread.  
Therapy for spread tumors, that can’t be surgically removed, is actually based on 
chemotherapy and radiotherapy with well-known side effects on healthy tissues. 
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Since immune response is highly specific, a cure based on anti-tumor immunity 
which can be extremely selective against unhealthy tissues has long being hoped. 
In many cancer forms tumor antigen-specific monoclonal antibodies have been 
tested, usually conjugated with powerful toxins; these antibodies binds to target cells 
activating host’s immune system or delivering toxins to neoplastic cells. 
Patient’s therapeutic treatment with immunological techniques is called 
immunotherapy. 
Many innovative immunotherapy strategies are based on stimulating patient’s 
immune response against neoplastic cells, for example through vaccinating with cells 
of its own tumor or with antigens derived from them. 
Another technique is called “adoptive cellular immunotherapy” and is performed 
inoculating tumor-specific lymphocyte on patient.75 
As we have seen, antibodies are of crucial interest in cancer research due to their 
high specificity against antigens which are overexpressed by tumor cells. 
Nanomedicine takes advantage of this specificity by functionalizing antibodies on 
nanosystems so they become smart structures. Some examples of antibody 
functionalized nanosystems were provided in previous subchapter. In this thesis 
antibody functionalized magneto-plasmonic nanostructures will be synthetized and 
characterized with particular regard to antibody functionality. It will be shown how 
selective can be a nanostructures when it is engineered with an antibody. 
Prostate cancer 
In last decade, prostate cancer has become most frequent tumor in male population of 
occidental countries. At the basis of this phenomenon, beyond the presence of risk 
factors, there is the greater probability of diagnosing this disease, which is present in 
a latent form in 15-30% of individuals over 50 years old and in about 70% of 
octogenarians.76 
Prostate cancer is one of the fifth most common cancers: in Europe in 2012 had an 
incidence of 22.8% with a mortality of 9.5% which make it the third for mortality 
after lung and colorectum cancer (Figure 1.7).77 
Actuals screening methods consists in detection of PSA (Prostate Specific Antigen) 
antigen on blood or in digital rectal exam. However diagnosis is confirmed only after 
a biopsy of prostatic tissue. 
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Other antigens, beyond PSA, that are overexpressed by prostatic cancer cells are 
PSCA (Prostate Stem Cell Antigen) and PSMA (Prostate Specific Membrane 
Antigen). These antigens can be recognized by specific antibodies. In this thesis we 
will use the antibodies specific for PSMA antigen, which is called D2B. This 
antibody, functionalized onto our nanostructure, will help recognizing cells that 
express PSMA antigen (indicated as PSMA+ cells). 
 
  
Figure 1.7 Distribution of the expected cases and deaths for the 5 most common 
cancers in Europe 2012 in males. The area of the segment of the pie chart reflects the 
proportion of the total number of cases or deaths.77 
 
Synthesis of nanoparticles: top-down 
and bottom-up methods 
Several synthesis strategies are available to synthetize nanoparticles of different 
composition and morphology, but in a very general way there are two approaches: 
top down and bottom up (Figure 1.8). 
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Figure 1.8 Artistic representation of top-down and bottom-up approaches.78 
A top-down method, called also physical method, consists in a reduction of 
dimension of bulk material untill it reaches desired nano dimensions. This is made 
through mechanical and/or physical processes which removes or divides bulk 
material. Some examples are ball milling, lithography, machining, radiolysis, 
sonolysis, thermolysis, photochemistry and laser ablation. These methods are usually 
less used than bottom up methods because in some cases they require dedicated or 
quite expensive instrumentation. Furthermore, if not well optimized, size and 
morphology of nanoparticles are difficult to control, like in ball milling process. Less 
use of chemicals is a characteristic of these methods. In this thesis a top-down 
method to synthetize both gold and iron oxide nanoparticles will be used: Laser 
Ablation Synthesis in Solution (LASiS), for which a special section is provided at the 
end of the introduction.79 
On the other side, bottom-up methods starts from molecules, atoms or even small 
nanoparticles to build more complex nanoparticles of the desired size and 
morphology. In this case the most common strategy consists in the controlled 
reduction of metal ions in solution. Controlling the nucleation and growth processes 
with the use of stabilizing agents, one obtains nanoparticles of the desired size and 
morphology. Other conditions, which affect these syntheses are temperature, time, 
pH, the choice of the reductant, solvents, the metal ion compound, the use of 
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emulsions or micelles and clearly the proportions between reagents. Since many 
parameters are involved in bottom-up methods, there are plenty of methodologies to 
synthesize the same type of nanoparticle. Usually with these strategies one can obtain 
nanoparticles of the desired morphology and with a narrow size distribution simply 
choosing the right synthesis and opportunely varying reagents proportions. However, 
some drawbacks regarding the use of chemicals or stabilizers which could be 
potentially toxic cannot be underestimated, especially when such nanoparticle are 
synthetized for biomedical purposes. Besides metal ion reduction, other processes are 
frequently used like vapor phase deposition (VPD), physical vapor deposition (PVD) 
and chemical vapor deposition (CVD).  
As said above, there are many bottom-up strategies for the synthesis of the same type 
of nanoparticles. The most common for gold and iron oxide nanoparticles will be 
briefly described in dedicated paragraphs and one of them will be utilized in trying to 
create a continuous gold layer in the nanostructures discussed in this thesis. 
In this thesis another bottom-up method, which is part of a class of reactions called 
sol-gel, is used to synthetize a silica shell around iron oxide nanoparticles. Sol-gel 
methods are quite different with respect to more common salt reduction synthesis. 
They involve a set of chemical reactions which irreversibly convert a homogeneous 
solution of a molecular reactant precursor (sol) into a very large molecular weight 
three-dimensional polymer (gel) forming an elastic solid filling the same volume as 
the solution. Typically this involves a hydrolysis reaction followed by condensation 
polymerization. In nanoparticles synthesis, sol-gel methods are commonly used to 
obtain silica nanoparticles or hybrid metal-silica nanostructures. The process of 
formation of silica nanoparticles by sol-gel method passes through the same process 
steps as reduction methods, that is nucleation and growth, and have to be stopped 
when desired NP size is reached, before a continuous polymer is formed (usually 
separating formed NP from reagent mixtures). The Sol-gel method used in this thesis 
is described in section Iron oxide nanoparticles – A sol-gel approach to surface 
modification.79  
Gold nanoparticles 
We have seen that gold nanoparticles are crucial tools in nanomedicine and due to 
their properties are fundamental also for other research topics (catalysis, 
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electrochemistry, supramolecular chemistry, non-linear optics etc.). The size and 
morphology of nanoparticles can vary considerably their properties and, as a 
consequence, also the field of application can vary. For this reason several synthesis 
strategies are available for AuNPs, mainly emerged in 20th century, through which 
one can obtain gold nanoparticles of the desired size. Below, one can find most 
employed bottom-up and top-down syntheses for AuNPs, followed by explanation of 
chemical and optical properties useful for the work in this thesis. 
Synthesis strategies 
Citrate reduction 
Among all synthesis methods this is the most used and consists in the formation of 
AuNPs of ca. 20 nm reducing Au(III) ions from chloroauric acid (HAuCl4) with 
trisodium citrate in water. This is also called Turkevitch method which was 
introduced in 1951. Modifications were introduced by Frens in 1973: in its studies he 
obtained gold nanoparticles with sizes from 16 nm to 147 nm varying the proportions 
between gold and citrate (or other stabilizers). In these nanoparticles citrate is also a 
stabilizer (unless other stabilizers are used) and for this reason they show a negative 
surface charge due to deprotonated carboxylic groups of citrate. Although there is a 
good size control using this method, presence of citrate can influence subsequent 
surface functionalization since ligand-exchange reactions are involved. Lastly several 
washing steps are required to eliminate the presence of citrate residues which can 
interfere with in vivo or in vitro biological experiments.14 
Brust-Schiffrin method 
Published in 1994 this method allows to obtain nanoparticles from 1.5 to 5.2 nm with 
a narrow distribution. Another peculiar characteristic is that as synthetized AuNPs 
can be dried and redissolved in common organic solvents without incurring in 
irreversible aggregation. 
The synthesis takes place in a two-phase systems and use alkanethiols as stabilizers. 
AuCl4- is transferred in toluene using tetraoctylammonium bromide as phase-transfer 
reagent and reduced using NaBH4. Varying the proportions between gold and ligands 
different sizes are obtained. In particular the increasing of ligand concentrations 
reduces the size of synthetized nanoparticles.14 
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Seeding-growth method 
This is a very popular method which consists in performing a classical Au (III) 
reduction from HAuCl4 in a solution containing pre-existents gold nanoparticles 
called seeds. Common reductants can be used in this method like citrate, NaBH4, 
formaldehyde or hydroxylamine hydrochloride. In this synthesis, Au ions reduce on 
seeds surface, increasing their dimension. AuNPs in range between 5-40 nm are 
obtained by varying seed-metal ion ratio. Gold nanorods can be synthetized using 
seeding-growth method.14 
Others reduction methods 
Perrault method uses hydroquinone to reduce gold ions in a solution containing gold 
seeds. Nanoparticles between 30-300 nm can be obtained. Citrate or other stabilizers 
are needed in this synthesis.80 
Martin method is another reducing method which is interesting because allow to 
obtain naked gold nanoparticles in water. With the precise control of NaBH4-NaOH 
to HAuCl4-HCl ratio one obtains AuNPs between 3-6 nm. These nanoparticles are 
stable in water thanks to charge stabilization, but should be usually purified from 
NaBH4 residues.81 
Navarro method implies the use of sodium acetylacetonate for the reduction of 
Au(III) to Au(I) immediately followed by addition of citrate for reduction of Au(I) to 
Au (0). Sodium acetylacetonate impacts on nuclei number and induce a size 
evolution of the core up to 90 nm with a narrow distribution.82 
Concluding, others significant methods involves the use of micelles or 
microemulsions. Technically speaking these are two-phase methods in which 
surfactants forms micelles or microemulsions creating a favorable microenvironment 
for the reduction of metallic ions. Au ions are extracted from aqueous to an organic 
phase or viceversa depending if normal or reversal micelles are used. This is an 
advantage respect to the conventional two-phase system because controlling the 
micelles dimension (also in conjunction with the presence of other stabilizers) one 
controls AuNPs size.14 
 
Physical methods 
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Physical methods differentiate from previous chemical methods because the 
formation of nanoparticles is not attributable to chemicals (reductants) but is 
provoked by physical phenomena. 
For example light irradiation can be used to synthetize gold nanoparticles in 
solutions. In literature we find that UV irradiation can reduce HAuCl4 in water 
solution in the presence of capping agents83 to form stable AuNP. 
Besides UV, other light sources can be used in AuNPs synthesis like NIR84 and 
microwaves.85 
Sonochemical methods make use of an ultrasonic field to reduce gold ions and form 
AuNPs.86 In this case parameters to be considered are the temperature of the solution, 
the ultrasound frequency and intensity and the positioning of the reactor. Sonolysis 
was also used to deposit gold nanoparticles on silica spheres.87 
Radiolysis and thermolysis are also alternative physical methods for the preparation 
of gold nanoparticles: the first use -irradiation to synthetize or control the size of 
AuNPs while the second use high temperature to increase size of gold cluster or 
nanoparticles.14  
Laser ablation synthesis in solution is also part of this category and implies the use of 
pulsed laser source to synthetize gold nanoparticles. 
Although physical methods are less used with respect to chemical methods they have 
an unquestionable advantage that is the absence, in the synthetic route, of reductants 
thus making the entire process more clean and green. 
 
Localized surface plasmon resonance (LSPR) 
Gold nanoparticles possess very different characteristics with respect to bulk gold 
which are mainly due to their nanometric size. The most important is the localized 
surface plasmon resonance (LSPR), which is responsible for the ruby red color of 15-
20 nm AuNP in solution. The origin of the phenomenon is the coherent oscillations 
of the conduction band electrons induced by an interacting electromagnetic field. 
Small enough (15-20 nm) gold nanoparticles strongly absorbs 520 nm green light, 
meaning that this photon frequency is in resonance with collective oscillation of 
conduction band electrons which is called localized surface plasmon resonance. The 
term “localized” is used when surface plasmons are confined to metallic 
nanoparticles or nanostructures. 
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Figure 1.9 represents the LSPR behavior in metallic nanoparticles. 
 
Figure 1.9 In gold nanoparticles, the coherent oscillation of conduction band 
electrons induced by an interacting electromagnetic field is called localized surface 
plasmon resonance (LSPR). 
 
When the electric field of an incoming light interacts with a plasmonic nanoparticle it 
induces a polarization of the free conduction electrons. Positive charges are assumed 
to be immobile while negative charges (electrons) moves under the influence of the 
electric field. This movement creates a net charge difference at nanoparticle 
boundaries which, in turn, gives rise to a linear restoring force. The result is the 
creation of a dipolar oscillation of electron called surface plasmon oscillation.88 
For many metals like Pb, In, Hg, Sn, Cd, LSPR lies in the UV region so 
nanoparticles of these metals doesn’t appear colored. But for coining metals (Au, Ag, 
Cu) the situation is different and thanks to d-d transitions they have an LSPR in the 
visible spectrum.14,88 
Gustav Mie in 1908 was the first to rationalize the observed red color of gold 
nanoparticles in water. His theory starts with two assumptions: (i) the particle and the 
surrounding medium are considered homogeneous and describable by their bulk 
optical dielectric functions and (ii) particle diameter is much smaller than the 
incident wavelength (2R<< where R is nanoparticle radius and  the incident 
wavelength). The last assumption allows considering the electric field constant all 
along the nanoparticle so the interaction can be considered electrostactic rather than 
electrodynamic (also called quasi-static approximation). 
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The solving of Maxwell’s equations lead to an expression of extinction cross section 
ext (ext =abs + sca = absorption cross-section + scattering cross-section) for 
metallic nanoparticles (equation 1.1): 
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Equation 1.1 
 
where  is the angular frequency of the exciting light, c is the speed of light, 
V=4/3r2 is the volume of the spherical particle, m and      are 
the dielectric functions of the surrounding medium and of the material (real and 
imaginary part).89 
When the term at the denominator reaches its minimum, extinction cross-section 
reaches its maximum, in correspondence of the maximum of the surface plasmon 
band. Looking at the dielectric function of metals, one finds that this happens when 
  ; in this condition the local electric field of the particle is enhanced. 
From Mie theory one can understand the relevance of the material and, clearly, of the 
solvent in determining the position of the surface plasmon band, since diverse 
materials and solvents possess different dielectric functions. 
LSPR not only depends on material and solvent, but it can considerably change 
depending on nanoparticles size, morphology and ligands. 
For larger nanoparticles (greater than  40-50 nm for gold nanoparticles) the dipole 
approximation is no more valid because light can’t homogeneously polarize the 
nanoparticle. In this case multipole forms and, as a consequence, retardation effects 
of the electromagnetic field across the particle can cause broadening and red-shifting 
of the LSPR (Figure 1.10 A). On the contrary, reducing the size of gold nanoparticles 
below 5 – 4 nm leads to a decrease of LSPR intensity accompanied by a slight blue 
shift (Figure 1.10 B). This is due to the onset of quantum size effects which become 
important for particles smaller than 2 nm.88 
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Figure 1.10 LSPR variations for gold nanoparticles with R<20 nm (A) and R>20 nm 
(B).  
 
The morphology of nanoparticles has also a considerable effect on LSPR. In the case 
of nanoparticles that deviate from sphericity, Gans’s modifications to Mie’s theory 
have to be taken on account. In particular, Mie-Gans theory is valid for ellipsoidal 
nanoparticles: in this case the longitudinal and transverse dipole polarization does not 
produce equivalent resonances. 
As a consequence two plasmon resonances forms and two peaks appear in the 
extinction spectra.  
Longitudinal plasmon refer to electron oscillation along the major axis of the ellipse 
and shows a broaded red-shifted peak while transversal plasmon refers to electron 
oscillation perpendicular to long axis and shows a peak at about 520 nm like for 
spherical particles (Figure 1.11). This phenomenon is clearly observable in nanorods 
spectra, for which the distance between the two peaks is correlated with their aspect 
ratio.88,89 
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Figure 1.11 The extinction spectra of nanorods (or non-spherical particles) shows 
two plasmon peaks because transverse and longitudinal dipole polarization doesn’t 
produce equivalent resonances. 
 
Therefore, the extinction spectra of nanoparticles can provides information on the 
size and the morphology of AuNP. In this thesis, for example, a software developed 
by the group in which the work for the thesis is done, is used to fit the spectra of just 
synthetized AuNP to estimate their size, sphericity and concentration using Mie and 
Mie-Gans theory.90 
Mie-Gans theory is only applicable to non-interacting nanoparticles, which are well 
separated from each other. 
In the case of aggregates of gold nanoparticles the plasmon oscillation drastically 
change because now particles are electronically coupled to each other because of 
dipole-dipole interactions. This leads to more complicated extinction spectra which 
depend on the size and shape of the formed aggregate. Aggregation causes a 
coupling of AuNPs plasma modes resulting in a red-shift and broadening of the 
longitudinal plasmon resonance. Usually extinction spectra of gold nanoparticles 
aggregates are a composite of conventional plasmon resonance due to single 
spherical particle (at about 520 nm) and a new red-shifted broaden peak due to 
particle-particle interactions.89 Extinction spectra of AuNPs aggregates can also be 
predicted with theoretical calculations, however this issue goes beyond the aim of 
this thesis. A good explanation of optical properties of AuNPs aggregates is provided 
in the review by Gosh.89 
LSPR of noble metal nanoparticles has a relevant importance in the explanation of 
the surface enhanced Raman scattering (SERS) effect, which is fundamental in this 
work.  
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Raman spectroscopy 
Raman spectroscopy is a vibrational spectroscopy based on the Raman effect, which 
was discovered in 1928 by Chandrasekhara Venkata Raman. It is based on the 
inelastic scattering of photons by matter. The phenomenon can be explained using a 
molecular energy diagram.  
 
Depending whether the molecule is in its vibrational ground state or first excited 
state (n=0, 1), the Raman scattered photon is shifted to lower or higher energy with 
respect of the incident photon h!L. Lower energy scattered photons are called Stokes 
scattered and have energy h!S=h!L-h!M while higher energy scattered photons are 
called anti-Stokes scattered and have energy h!aS=h!L+h!M. The difference between 
incident and scattered photons, h!M is the vibrational energy of a normal mode of the 
molecule (Qi). The Raman scattering power PRS is proportional to the number of 
molecules in the probed volume, the Raman cross section of the molecule R and the 
intensity of incident light IL. Generally, anti-Stokes signals are weaker than Stokes 
because, according to Boltzmann statistics, since only a small fraction of molecules 
are in their excited state. From a classical point of view the incident radiation 
generate an oscillation of the induced dipole "ind which, in turn, depends on the 
molecular polarizability # and the incident electric field E(t) ("ind=#$E(t)). From this 
dependence derives the selection rule for Raman spectroscopy, which implies a 
change in polarizability for the investigated vibrational mode  	  0.  
Surface Enhanced Raman Scattering (SERS) 
Surface enhanced Raman scattering is a phenomenon in which amplification of the 
Raman signals of a molecule are observed when it’s close to the surface of a noble 
metal nanoparticle. 
In the following box the Raman effect is briefly recalled. 
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SERS was observed for the first time in 1974 by Martin Fleischmann, who recorded 
an unexpected strong Raman signal of pyridine electrochemically adsorbed on a 
roughed silver electrode. Lately, in 1977, Richard Van Duyne and his coworker 
David Jeanmarie ascertained that the observations by Fleischmann were effectively a 
genuine enhancement of the Raman signal. This discover kicked off researches on 
SERS and its applications in several fields, which nowadays are still of actual 
importance. 
Raman signals are weak because of the low Raman cross section which range 
between 10-30 cm2 and 10-25 cm2 with the larger value observed in resonant 
conditions (when the excitation wavelength matches an electronic transition). For 
comparison, fluorescence cross section ranges between 10-17 cm2 and 10-16 cm2.91,92 
With surface enhanced Raman scattering, Raman signals can be enhanced by a factor 
from 104 to 1014 so becoming comparable with fluorescence intensity. 
Three parameters have to be considered to obtain good SERS signals: the substrate, 
the analyte (also called SERS reporter) and the laser wavelength. 
Usually, SERS substrates are nanopatterned surfaces or nanoparticles made of noble 
metals. The phenomenon at the basis of SERS is, in fact, the localized surface 
plasmon resonance (LSPR). The LSPR plays the major role in explaining one of the 
two enhancing mechanisms for Raman signal in SERS: the electromagnetic 
enhancement, which is also the most important. 
When light is in resonance with LSPR, the dipolar oscillation generates a strong 
electromagnetic field ESP on the surface of a nanoparticle. The magnitude of that 
field depends on the nanoparticle radius r, the dielectric constant of the metal , its 
distance d from the molecule and the incident field strength E0 (Equation 1.2): 
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The molecule on the surface of nanoparticle experiences an enhancement of the 
electromagnetic field which is sum of the two electromagnetic fields (Equation 1.3): 
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The enhanced electric field has direct impact in the induced dipole "ind of the 
molecule thus leading to a drastic increase in the Raman signals. 
The total enhancement factor GSERSEM is given by the product of the individual 
enhancement factor of the laser |A(!L)|2 and of the Raman scattered fields |A(!S)|2 
which, in turn, is determined by the ratio EM/E0. 
Considering that Stokes shifts are small, !S and !L are almost the same frequency and 
the electromagnetic enhancement factor depends, therefore, on E4.91 Recalling 
equation 1.2, one can also see that the enhancement factor reaches its maximum 
when the condition   + is satisfied which happens when light is in resonance 
with surface plasmons and the imaginary part of the dielectric function of the metal 
nanoparticle is small. 
The power of Raman signal in SERS depends on the number of molecules involved, 
the laser intensity, the two enhancement factors |A(!L)|2 and |A(!S)|2 and the effective 
Raman cross section of the molecule (Equation 1.4)92: 
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However, electromagnetic enhancement is not the only mechanism explaining SERS. 
In fact, electromagnetic enhancement should be a non-selective amplifier for Raman 
signal of molecules adsorbed on nanoparticles. In practice, studies reported that CO 
and N2 molecules differ by a factor of 200 in their SERS intensities under the same 
experimental conditions. These observations suggested that another mechanism takes 
part in SERS enhancement: the chemical enhancement (sometimes called also 
electronic enhancement).93 
Debate is still open on how exactly the chemical enhancement works but electronic 
interactions between the adsorbed molecule and the metal seems to be the driving 
force for this mechanism. In fact, it is not uncommon that lowest unoccupied 
molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) of a 
molecule are almost symmetrically disposed in energy with respect to Fermi’s levels 
of the metal (Figure 1.12). In this situation, charge-transfer excitations can occur at 
about half the usual energy and considering that most of common SERS reporters 
have their lowest-lying electronic transition in the UV region, with this model charge 
transfer excitations occur in the visible region. When the electron returns to its initial 
state, emits a Raman shifted photon.92,93 
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Figure 1.12 Diagram showing interactions leading to charge transfer excitations 
between HOMO and LUMO of a molecule with Fermi’s levels of a metal 
nanoparticle.93 
 
Metal-molecule interactions like energy transfer to metal nanocore or intramolecular 
interactions are also involved in the quenching of molecule’s fluorescence, allowing 
the observation of clear Raman signals without being covered by fluorescence 
emissions (Figure 1.13).94  
  
Figure 1.13 Examples of non-radiative processes implied in fluorescence quenching 
of Raman reporters.94 
 
This is important since mostly used Raman reporters are dyes which absorbs in the 
visible region. 
Experimental evaluation of enhancement factors can be obtained by equation 1.5:91 
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Equation 1.5 
in which ISERS and NSurf are the SERS intensity (at a given wavenumber) and the 
number of molecules bound to the metal substrate while INRS and NVol are the normal 
Raman signal intensity and the number of molecules in the probing volume. 
Choosing the right setup for obtaining an enhancement factors of 1014 a single 
molecule SERS spectrum have been recorded, making SERS a very powerful  tool.42  
There are some parameters which, if optimized, allows to obtain a good enhancement 
factor, namely a huge Raman signal. As recalled above, three are the parameters to 
consider: the excitation wavelength, the substrate and the SERS reporter. 
Optimization of excitation laser wavelength 
The enhancement of the electric field of nanoparticles or nanopatterned surfaces 
occurs when LSPR or SPR is excited. Noble metal nanostructured materials (Au, Ag 
Cu) have their LSPR or SPR excitation in the visible range, so most commons laser 
sources are suitable in performing SERS measurement.91 Practically, one chooses the 
wavelength of excitation as a function of the SERS substrate. Other parameters like 
irradiation time, number of acquisition spectra and laser intensity have to be tuned 
experimentally, time by time. 
Optimization of the substrate 
The size and morphology of the nanostructures on the substrate strongly influence 
the SERS intensity. The following considerations are restricted to gold nanoparticles, 
considered in this thesis, but can be extended to other metal nanoparticles.  
If we consider spherical AuNPs, the upper limit in size to obtain good SERS signal 
correspond to that in which the dimension of the nanoparticle is comparable to the 
excitation wavelength (d>100 nm). In this case incident electric field does not 
polarize homogeneously the nanoparticle, the quasi-static approximation fails and 
multipole excitations must be considered. Unlike the dipole, these modes are non-
radiative and hence are not efficient in exciting Raman excitations. Consequently, 
going up with size (500-1000 nm) the light is scattered rather than absorbed, so less 
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inelastic scattering occurs at the surface which leads to a weakening of the 
electromagnetic field on the surface and the overall SERS intensity.95 
On the other side of the dimensional scale, when nanoparticles are very small (d<5 
nm), the onset of quantum size effects become important, the LSPR is damped and 
conditions to perform SERS are no longer presents. Taking in account these 
considerations, the optimal size to perform SERS is with AuNP from 10 nm to 
almost 90-100 nm. 
The morphology plays also an important role in defining the parameters for good 
SERS signals. Intense signals are obtained using star shaped AuNPs due to huge 
field enhancement in star tips.96  
Using spherical nanoparticles, like in this project, huge field enhancement are 
obtained when nanoparticles are close together forming dimers, trimers, or more 
large aggregates. If a molecule resides in the region between particles it feels a huge 
enhancement of the electric field (if compared to the isolated nanoparticle) due to 
constructive coupling of the two localized surface plasmons. The mutual interaction 
of the two nanoparticles leads to an increase of the magnitude of the induced dipole 
which, in turn, leads to amplification in the polarization (Figure 1.14).93,95,97 
The region between the two nanoparticles is called hot spot and enhancement untill 
1011 can be easily observed. Since the field around nanoparticles decay with r-3, one 
condition for hot spot is that interacting particles have to be very close (i.e. <1 nm) to 
the surface.95 It must also be recalled that when nanoparticles couples their plasmons, 
new features of LSPR emerge (longitudinal and transversal plasmon excitation), so 
new component in extinction spectra have to be considered in choosing the right 
laser excitation wavelength. 
 
Figure 1.14. Graphical illustration of coupled surface plasmons and their effect on 
charge density distribution (left) and calculations of electromagnetic enhancement 
factors between two 15 nm gold nanoparticles (right).95,97 
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Optimization of the SERS label 
SERS label (or SERS reporter) can be considered the independent variable for this 
spectroscopy. This means that if the molecule it’s a prefixed analyte (for example 
drugs, metabolites, pollutants etc) other parameters (excitation source and substrate) 
have to be varied to find the best experimental condition to observe the most intense 
SERS signals. Clearly, conjugated molecules work better than unconjugated ones 
because molecular vibrations that involves  electrons induces biggest polarizability 
changes, thus leading to huge Raman responses. 
In the case of biological applications, the purpose is to obtain the most intense 
signals as possible to be able to track or detect nanosystems in the biological 
environment. For this reason a careful selection of the SERS reporters have to be 
done. In this case, spectroscopic characteristics of the reporter have to be taken in 
account. In particular, when the exciting photons energy overlaps the electronic 
transition energy of the SERS reporter, the Raman scattering intensity are strongly 
enhanced.96 When this condition is satisfied one talks about surface enhanced 
resonance Raman scattering (SERRS), which allows to obtain enhancement up to 
1014.42 Since, usually, excitation wavelength and LSPR lie in the visible range, 
SERRS is performed using dyes with an absorption in this spectrum range. 
Another condition for strong SERS signals is that the reporter molecule must reside 
within the space where the electromagnetic field is enhanced by excitation of LSPR. 
For favoring this situation, it is usually convenient to conjugate the dye directly to 
the surface of the nanoparticles. Conjugation can be performed either by 
physisorption or chemisorption and in both case the characteristics of metal 
nanoparticles have to be considered. For gold nanoparticles chemisorption of labels 
is performed exploiting Au affinity for thiols and amino groups, while physisorption 
usually depends on nanoparticles surface charges. For example for nanoparticles with 
negative surface charges, cationic dyes are to be used. 
In this project, all the considered nanosystems have been engineered to exploit 
SERRS activity. 
An advantage in using SERS/SERRS for biological applications is its high sensibility 
comparable to fluorescence. Moreover, with SERS nanostructures, more labels can 
be excited using the same wavelength, and this allows to perform multiplexed 
analysis in which one spectra can contain information coming from various labels 
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easily distinguishable in the fingerprint region. This is possible only thanks to the 
narrow signals of Raman spectra. The same is not possible in the case of 
fluorescence, where bands from diverse fluorophores overlaps and has to be excited 
at different wavelengths. 
Plasmonic photothermal effect 
Another feature of gold nanoparticles directly connected to the presence of LSPR is 
their ability of generating heat when irradiated. This phenomenon is called plasmonic 
photothermal effect and can be explained as a four step process (Figure 1.15): 
 
Figure 1.15 Various steps involved in plasmonic photothermal effect. Incident 
photon is absorbed (a) and then non-radiative effects generate hot carriers (electron-
hole pairs) (b). After electron-electron and electron-phonon relaxation (c), thermal 
dissipation occurs (d).98 
 
1. Excitation of a plasmon band creates hot electrons as a consequence of 
photon absorption by the metal nanoparticle. Absorption is enhanced when 
light source has the same wavelength of plasmon excitation. (Figure 1.15a) 
2. Plasmon resonance relaxes radiatively with re-emission of a photon or non-
radiatively with creation of an electron-hole pair via Landau damping. This 
last is the necessary decay mechanism to obtain photothermal effect. Here a 
plasmon quantum is transferred to a single electron-hole pair excitation. 
(Figure 1.15b). 
3. The work function (the energy required to emit an electron into vacuum) of 
metals are generally higher than the LSPR energies %LSPR so that hot 
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electrons can have energies raging between the Fermi level EF to EF+ %LSPR 
and do not escape into vacuum. For this reason their energy is first dissipated 
through electron-electron scattering processes and then electron-phonon 
interactions.  
4. Last step is lattice relaxation and heat transfer to surrounding medium.98 
 
The importance of the plasmon resonance and excitation wavelength is relevant. 
Most efficient photothermal effect is obtained when laser source is in resonance with 
surface plasmons. As seen above, size and morphology of nanoparticles determines 
the position of LSPR absorption band and, as a consequence, the excitation 
wavelength to obtain efficient photothermal effect.99,100  
In section “Gold nanoparticles in cancer research” at page 16, it was recalled that 
heat generated by nanoparticles is used to kill cancer cells. Clearly, an LSPR in NIR 
is often preferred. In NIR region, light penetration in tissue is optimal because 
absorptions by tissues and skin pigments are limited. Nanoshells with a silica core 
and a variable gold shell, nanocages and nanorods are promising structures for NIR 
plasmonic photothermal therapy (PPTT). They are interesting because even if their 
synthesis is not so simple, by finely tuning shell thickness in nanoshells, number of 
holes and wall thickness in nanocages and aspect ratio in nanorods, one can tune the 
LSPR to a desired position in spectrum (figure 1.16).98-101  
However, visible absorbing gold nanoparticles are a good starting point for PPTT 
studies and can successfully applied in subcutaneous tumors treatment. Furthermore, 
their aggregation shifts the plasmon resonance in the NIR spectral region as required 
by an efficient photothermal effect. 
Besides tumor treatment, plasmonic photothermal effect can be used for other 
purposes. A strange example that could open the way to other applications is the 
work of Halas’s group in which they used heat from gold nanoparticles to distillate 
ethanol. The entire process requires less energy than conventional distillation 
methods and a substantially higher mole fraction is obtained.102  
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Figure 1.16 By varying morphological aspects of diverse gold nanostructures, one 
can tune the LSPR from visible to NIR to match the optimal wavelength to perform 
plasmonic photothermal therapy.99 
Iron oxide nanoparticles 
In subchapter “Iron oxide nanoparticles in cancer research” the importance of 
FeOxNPs in biological applications has been recalled, emphasizing the fact that large 
nanoparticles (above several micrometers) are already commercialized for MRI or 
bioseparation uses. Many forms of iron oxides exist but three of them are the most 
commonly used in nanomedicine: magnetite (Fe3O4), maghemite (-Fe2O3) and, in 
less extent, hematite (#-Fe2O3). 
Among these three oxides, magnetite exhibits the strongest magnetism, followed by 
maghemite. 
The structure of the three iron oxides consists on planes of close-packed oxygens 
anions with iron cations distributed in octahedral or tetrahedral interstitial sites 
(Figure 1.17). Oxygens anions are in a cubic close-packed arrangement in magnetite 
and maghemite. Magnetite has a cubic inverse spinel structure with Fe2+ cations 
occupying half of the octahedral sites and Fe3+ cations distributed randomly between 
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tetrahedral and octahedral sites. Similarly to magnetite, maghemite has a spinel 
structure but with vacancies in the cation sublattice: two third of the sites are filled 
with Fe3+ regularly arranges ions, with two filled sites followed by a vacancy. One 
can also recall that, differently from magnetite and maghemite, in hematite (a very 
poor magnetic common iron oxide, #-Fe2O3) oxygen anions are arranged in a 
hexagonal close-packed lattice with Fe3+ cations occupying two-thirds of the 
sites.103,104 Table 1.6 resumes physical and chemical properties of the three iron 
oxides. 
 
Figure 1.17 Crystal structures of Hematite, Magnetite and Maghemite. (Fe2+=black 
ball, Fe3+= green ball, O2-= red ball).103 
 
Most commons synthesis of FeOxNPs, like AuNPs, involves the use of iron (II) and 
(III) salts. Clearly, varying the proportions between reagents or reactions conditions, 
one can obtain the three oxides selectively. 
 
Table 1.6 Physical and chemical properties of iron oxides.104 
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Some of the most used synthesis strategies are briefly described below, in particular 
for obtaining magnetite nanoparticles: the most interesting oxide because of its 
magnetic properties. 
Synthesis strategies 
Several methods are available for the synthesis of iron oxide nanoparticles. Like for 
gold nanoparticles, chemical routes are the most commonly used due to their relative 
simplicity and inexpensiveness (figure 1.18). However, physical and biological 
syntheses are sometimes preferred depending on the final applications.  
 
Figure 1.18 Comparison of published works (data of 2011) on the synthesis of iron 
oxide nanoparticles by chemical, physical and biological methods.105 
 
Coprecipitation method 
This is the most common method for the synthesis of iron oxide nanoparticles. It is 
based on the simultaneous precipitation of Fe3+ and Fe2+ ions in basic conditions: 
Fe2+ + 2Fe3+ + 8OH-  Fe3O4 + 4H2O 
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If performed with a stoichiometric ratio of 2/1 (Fe3+/Fe2+), magnetite nanoparticles 
are obtained. The pH of the solution has to be within 8 and 14 and reaction has to be 
performed in a non-oxidizing environment, which is usually obtained with a nitrogen 
flux. In fact, magnetite is not very stable and is sensitive to oxidation, which leads to 
the formation of maghemite: 
Fe3O4 + 2H+  Fe2O3 + Fe2+ + H2O 
The main advantage in the coprecipitation method is that large amounts of particles 
can be obtained, with narrow sizes ranging from 2nm to 17 nm. Sizes and shapes can 
be controlled varying reaction conditions (pH, temperature, time, injection fluxes and 
ionic strength of the environment). Carboxylated chelating agents (such as citric, 
gluconic or oleic acid) or polymer surface complexing agents (dextran, starch, 
carboxydextran or PVA) must be used during the formations, for stabilizing the 
nanoparticles and allows to control the size of nanoparticles and contribute to their 
stabilization.47 
Micelles or water-in-oil microemulsion method 
Similarly to AuNPs, micelles or water-in-oil microemulsions are quite often used for 
the production of iron oxide nanoparticles. The mechanism of nanoparticles 
formation is based on the coprecipitation method, but nucleation and growth occur 
inside the micelles/inverse micelles. With this method iron oxide nanoparticles from 
2-3 nm up to 100 nm can be obtained. An advantage of this synthesis is a good size 
control, which in turn depends on micelles/emulsion dimension. Clearly, depending 
on the surfactant used and solution properties, different sizes can be obtained. Also in 
this case, the use of stabilizers is needed: they can be in solution but sometimes the 
micelles are studied to act also as stabilizers when a desired size is needed. One of 
the drawbacks of this synthesis method is the use of potentially toxic surfactants and 
solvents, which, in particular sensitive environment, like the biological, can create 
potential problems.47,103,106 
Hydrotyhermal and thermal decomposition methods 
In hydrothermal synthesis, aqueous solutions of iron salts or organometallic 
precursors are treated in closed vessel at high temperature (130-250°C) and high 
pressure (0.4-4 mPa). These conditions allow nucleation and growth of iron oxide 
nanoparticles with narrow size distributions. In thermal decomposition method, 
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nanoparticles forms after the decomposition at high temperature of organometallic or 
coordinated iron salts in organic solvents. Commons ferric salts include Fe(CO)5, 
Fe(acac)3 (acac = acetylacetonate), iron oleate, Fe(Cup)3 (Cup = N-
nitrosophenylhydroxylamine), Prussian blue (Fe4[Fe(CN)6·14H2O], Fe–urea complex 
([Fe(CON2H4)6](NO3)3), ferrocene (Fe(C5H5)2), and Fe3(CO)12. 
Iron oxide nanoparticles produced with thermal decomposition synthesis show 
crystallinity and narrower size distribution with respect to the co-precipitation 
synthesis. With this method stabilizers are needed and nanoparticles are soluble only 
in non-polar solvents. The use of potentially toxic stabilizers or precursor and the 
impossibility to dissolve nanoparticles in aqueous solvents make these nanoparticles 
less suitable for use in nanomedicine.103,106  
Other chemical methods 
Electrochemical synthesis allows to obtain maghemite or magnetite nanoparticles. 
The synthesis is performed using an iron electrode immersed in aqueous solution of 
DMF. Adjusting the current density it is possible to control nanoparticles sizes. 
Another method which is a valid alternative to thermal methods is sonolysis. Here 
ultrasounds generate cavitation bubble which release high quantity of energy when 
they collapse. This energy, in the form of high pressure and temperature, enable the 
decomposition of organometallic precursor (like in thermal synthesis) thus leading to 
formation of iron oxide nanoparticles. Also in this case, stabilizers are needed to 
limiting the growth of nanoparticles.47,103 
Physical methods 
Regarding physical methods, the most used are spray and laser pyrolysis. In spray 
pyrolysis, a solution of ferric salts in organic solvents with a reducing agent is 
sprayed through reactors at high temperature, where the aerosol solute condenses and 
solvent evaporates. The dried residue consists of nanoparticles which size is 
determined by initial droplet size. Laser pyrolysis can be considered a gas-phase 
synthesis. In this case, an opportune laser heats a gas mixture in which an iron 
precursor is present. Heating generates small non-aggregated iron oxide 
nanoparticles.47 
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In this work iron oxide nanoparticles are synthetizes with laser ablation method, like 
for gold nanoparticles. A section dedicated to this physical method is provided 
below. 
Magnetic properties 
A material is said to be paramagnetic when the individual atomic magnetic moments 
are randomly aligned with respect to each other and, because of this, the neat 
magnetic moment is zero (see figure 1.19) 
 
Figure 1.19 The alignment of atomic magnetic moments in different materials.104 
 
If an external magnetic field is applied, some of these magnetic moments will align 
and the entire crystal will show a net magnetic moment. 
In a ferromagnetic crystal, all magnetic moments are aligned even without an 
external magnetic field while in a ferrimagnetic crystal (like magnetite) a net 
magnetic moment is also present, but it comes from two types of atoms with 
moments of different strength arranged in antiparallel fashion. When antiparallel 
moments have the same magnitude the crystal is said to be antiferromagnetic and no 
net magnetic moment is present. In a bulk ferromagnetic material, the magnetization 
M is defined as the vector sum of all the magnetic moments per unit volume. Bulk 
material contains domains with each domain having its own magnetization vector 
arising from the alignment of single magnetic moments. It is also probable that 
magnetization vectors of domains are not aligned to each other. For this reason the 
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global magnetization of the material is less than its value when all atoms magnetic 
moments are perfectly aligned (Figure 1.20). 
 
Figure 1.20 Magnetic domains in bulk materials.104 
 
However, when the length scale of the material become small, the number of 
domains decreases until a single domain is present, like for iron oxide nanoparticles 
under a certain critical size. 
Figure 1.21, shows the variation of the magnetization M when an external magnetic 
field with strength H is applied. 
 
Figure 1.21 Variation of the magnetization M under an external magnetic field H.104 
 
When the external magnetic field H is applied to a ferromagnet, the magnetization M 
increase with H untill saturation magnetization value MS is reached. The curve shows 
a hysteresis loop because domains do not return to their original orientation when H 
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decreases. For this reason, when H returns to zero, a residual magnetization MR is 
still present. MR can be removed applying a coercive field HC in the opposite 
direction respect of that originally applied. 
A single domain magnetic material has no hysteresis loop because no residual 
magnetization is present after magnetic field removal and is said to be 
superparamagnetic. Superparamagnetism is typical of iron oxide nanoparticles 
smaller than a certain size (20-30 nm), namely when their dimensions are 
comparable with that of a single domain. 
Above a certain temperature, magnetic materials lose their magnetization due to 
thermal fluctuations of individual magnetic moments, which lead to a disordered 
arrangement of the magnetic moments. For ferrimagnetic and ferromagnetic 
materials this temperature is the Curie temperature TC, while for antiferromagnetic 
materials it is the Néel temperature TN. Superparamagnetic nanoparticles maintains 
an ordered arrangement below the blocking temperature TB. 
The strong magnetic moment of iron atom derives from the four unpaired electrons 
in its 3d orbitals.  
Hematite is weakly ferromagnetic at room temperature and becomes paramagnetic 
above its Curie temperature at 956 K. It also undergoes a phase transition to an 
antiferromagnetic state at 260 K (Morin temperature, TM). Its magnetic behavior can 
be improved decreasing nanoparticles size (Morin temperature tends to vanish) while 
a poor crystallinity and substitution cations can lower also TC. For this reason, 
hematite nanoparticles are not the best choice for application like bioseparation 
because they are not efficient. 
On the other hand, magnetite is ferrimagnetic at room temperature and has a Curie 
temperature of 850 K and also possesses the highest saturation magnetization among 
the three metal oxides. Magnetite nanoparticles are superparamagnetic below 25-30 
nm. However this value depends on the synthesis route and particles morphology and 
in literature it is quite difficult to find an agreement on that value. Thanks to their 
magnetic properties, magnetite nanoparticles are the most preferred for 
biological/nanomedicine uses. 
Maghemite is also ferrimagnetic at room temperature, but it’s unstable at high 
temperature and loses susceptibility with time. At approximately 400°C undergoes 
an irreversible crystallographic change in hematite. For this reason its Curie 
temperature is difficult to estimate although it is supposed to be between 820 K and 
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926 K. Maghemite nanoparticles below 10 nm are superparamagnetic at room 
temperature. However, also in this case synthesis and morphology can affect 
magnetic properties. Maghemite nanoparticles can also be efficiently used for 
biological applications, as an alternative to magnetite nanoparticles. 
As stated above, magnetic properties of iron oxide nanoparticles strongly depend on 
the composition, the synthesis adopted, morphology and dimension. However, also 
subsequent surface modifications have demonstrated to contribute to variations in 
their properties.104 
Chemical properties 
Like gold nanoparticles, the chemical properties of iron oxide nanoparticles have 
been extensively studied. Surface modifications are, for these nanoparticles, of 
fundamental importance because they help to (i) improve FeOxNPs stability and (ii) 
give new properties to nanoparticles. In this last category the surface chemistry of 
iron oxide nanoparticles is used to introduce new functional groups, useful for further 
functionalization, but also to improve their biocompatibility. 
The stabilization of nanoparticles helps preventing their aggregation in biological 
medium and/or when exposed to a magnetic field (like in bioseparation assays). 
Generally, there are two major forces involved in interparticle interactions: van der 
Waals short-range attractive forces and electrostatic repulsive forces. The Derjaguin-
Landau-Verwey-Overbeek (DLVO) theory well describes these two forces. In the 
case of magnetic suspension, also magnetic dipolar interactions have to be taken into 
account.47 In the case of superparamagnetic nanoparticles, where no remanence and 
coercivity is found, the aggregation phenomenon is negligible at room temperature. 
With all these parameters, it’s easy to understand why the functionalization of iron 
oxide nanoparticles is a crucial point, especially when their final destination use is in 
biotechnology or nanomedicine. 
In general, nanoparticles can be stabilized exploiting the steric and/or electrostatic 
repulsions. Steric repulsion is often preferred because, once performed, aggregation 
is avoided also in the case of important changes in pH or ionic strength of the 
solution. Long polymer chains physisorbed or chemisorbed on nanoparticles surfaces 
are used in steric stabilization. 
Electrostatic repulsion is extremely sensitive to pH and ionic strength of the solution 
and can be followed through the knowledge of the Z-potential, a measure of the 
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surface charges given by the potential that they generate just outside the electrical 
double layer. However, electrostatic stabilized nanoparticles have the advantage of a 
bare surface, completely disposable for further functionalizations. 
In iron oxide, the iron atoms on the surface act as a Lewis acid and coordinate with 
molecules that donate lone-pair electrons. In aqueous solution, Fe atoms coordinate 
with water which readily dissociates leaving iron oxide surface hydroxyl 
functionalized. Due to amphoteric nature of –OH groups, they may react with acids 
or bases. For this reason, depending on the pH of the solution, the surface of 
magnetite can be positively or negatively charged. For magnetite nanoparticles, the 
isoelectric point (also called point of zero charge, PZC), is observed at a pH of about 
6.8, very close to that of biological environments.47  
At PZC, the charge density on nanoparticle surface is too small and they tend to 
aggregate, sometimes irreversibly (coagulation). 
Controlling both electrostatic and steric repulsion, one obtains stable nanoparticles. 
Functional groups like carboxylates, phosphates and sulfates are known to bind to 
magnetite surface. 
Citric acid is a common carboxylated stabilizer: it coordinates via one or two 
carboxylate groups, leaving the other group exposed to the solvent which is 
responsible of the negative surface charge and hydrophilicity.47 
Other frequently used carboxylated compounds are oleic acid and lauric acid, used 
for synthesis in organic solvents. 
To enhance FeOxNPs biocompatibility, very common coatings are polysaccharides 
and biopolymers like dextran, carboxymethylated-dextran, carboxydextran, starch, 
alginate, chitosan and carboxymethylcellulose. 
Polyehtylenglycole (PEG) is also a common biocompatible stabilizing agent, usually 
with a carboxy or phosphate terminal group.106  
Other polymers, with their advantages when used in iron oxide nanoparticles are 
listed in table 1.7. 
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Table 1.7 Organic natural and synthetic polymers used for FeOxNPs coating.106 
 
There is another coating, which is very common for iron oxide nanoparticles and 
provides new surface functionalities: the silica coating. 
A sol-gel approach to surface modification 
Silica is the most common compound for preparing functionalized iron oxide 
nanoparticles. This coating has three main advantages 103: 
1. Stability is improved and interparticle interactions (magnetic dipole 
interactions) are avoided. 
2. FeOx@SiO nanoparticles possess good stability and good biocompatibility 
and are hydrophilic. 
3. The technology for the synthesis of these nanocomposites is already mature 
and easy to control. 
The process involved is a sol-gel reaction and the most common is the Stöber 
synthesis107, also used in this project.  
Stöber synthesis has been named after the scientist who discovered this reaction in 
the ‘60s. In his work, “Controlled growth of monodisperse silica spheres in the 
micron size range”, he describes the synthesis of silica nanoparticle starting from an 
alcoholic solution of precursor. 
This sol-gel synthesis is a two-step reaction: in a first step, an organosilane precursor 
is dissolved in an alcohol/water solution in the presence of catalytic quantities of a 
base like ammonia. In these conditions the precursor hydrolyzes. The second step 
involves condensation of the hydrolyzed precursor in forming spherical silica 
nanoparticles. 
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If this reaction is performed in presence of other nanoparticles, like iron oxide 
nanoparticles, a shell of silica forms around them. 
Figure 1.22 shows the Stöber synthesis in the presence of iron oxide nanoparticles. 
 
Figure 1.22 Mechanism of the formation of a shell on iron oxide nanoparticles. The 
firsts two steps are called Stöber or sol-gel synthesis.103 
 
Here, the hydroxyl groups on the surface of iron oxide nanoparticles reacted with the 
methoxy groups of the silane molecule leading to the formation of Si-O bonds and 
leaving the terminal functional groups (-R) available. 
The simplest organosilane which can be used for this synthesis is TEOS 
(tetraethylorthosilicate). However, there is often the necessity to have specific 
functional groups on the surface, so that further reaction can be performed.  
In this case, precursor like APTES ((3-aminopropyl)triethoxysilane) or MPTMS ((3-
mercaptopropyl)trimethoxysilane) provides –NH2 and –SH groups respectively 
(Figure 1.23). 
Surface exposed amino groups could serve, for example, as a reaction site for 
terminal –COOH groups of a peptide to obtain bioactive nanoparticles. 
In chapter 3 of this thesis, the –SH groups of MPTMS coated iron oxide 
nanoparticles serves as binding site for gold nanoparticles to create a multifunctional 
magneto-plasmonic structures.  
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Figure 1.23 TEOS is the most simple organosilane precursor for Stöber reaction. 
MPTMS and APTES are used to obtain surface exposed thiol and amino groups 
respectively. 
 
Besides functional groups, the new composite structure can have a different surface 
charge with respect to iron oxide nanoparticles. MPTMS and TEOS coated 
nanoparticles present negative charges at physiological pH due to partially 
unprotonated –OH surface groups. On the other hand APTES gives rise to positively 
charged nanocomposites due to partially protonated amino groups at physiological 
pH. 
Considering that iron oxide nanoparticles have low Z-potential values (usually 0-10 
mV in absolute value) at physiological pH, the silica coating, either performed with 
TEOS, MPTMS, or APTES (or any other precursor) could give rise to Z-potential 
values up to 40 mV (in absolute value) thus contributing to a determining 
electrostatic stabilization. 
Magnetic composite nanomaterials can have different morphologies (Figure 1.24) 
depending on the synthesis strategy or the destination use.103 The most common is 
the core-shell structure with an iron oxide nanoparticle coated with a silica shell (also 
indicated as FeOxNP@Si or FeOxNP@SiO or FeOxNP@TEOS etc.). Other 
interesting structures are matrix-disperse structures in which, similarly to this project, 
more than one nanoparticles is embedded in the silica matrix. This type of 
nanostructure is useful in bioseparation because when exposed to a magnetic field it 
migrates faster than a single core-shell structure, so the separation time is drastically 
reduced.53 
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Figure 1.24 Different morphologies of nanostructured materials. Blue color is for 
iron oxide, while red and orange are other non-magnetic materials like silica or, for 
example, gold.103 
 
The last interesting characteristic of silica-coated nanoparticles is that small 
molecules, like fluorescent dyes, can remain embedded in the silica shell if the 
synthesis is performed in the presence of these molecules. At the end one obtains 
fluorescent magnetic nanoparticles that can, for example, be tracked using a 
fluorescent microscope.108 
This strategy will be used in this thesis in chapter 3, but, as it will be shown,  the 
particles will be used for SERS measurements.  
Common synthesis for magneto-
plasmonic materials 
There’s a wide literature on the synthesis of magneto-plasmonic materials, due to the 
multifunctionality that makes them an attractive tools in several fields. Earlier in this 
introduction some of their applications in cancer research were discussed. This 
subchapter will focus on some synthesis strategies of magneto-plasmonic materials, 
in particular those made of gold and iron oxide, with attention to the different 
morphologies which can be obtained. 
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Core-Satellite structures 
One of the most common hybrids Au-FeOx structures are of the core satellite type. 
This structure possesses a single core surrounded by multiple, usually smaller, 
nanoparticles of a different material called satellites. Core and satellites are linked 
each other through covalent bonds or other supramolecular interactions. The core 
must be bare or predisposed to functionalization with the opportune ligands for 
satellites linking. 
Due to numerous satellite nanoparticles, this structure possesses high surface area 
and is particularly suitable for uses in catalysis or for high chemical/biochemical 
loading. These structures are also the starting point for the synthesis of core-shell 
particles. 
The most common structure is FeOx@Au core-satellite because of the facile 
synthesis of the iron oxide core (50-300 nm, solvothermal route is preferred) and 
subsequent chloroaurate chemical reduction to form AuNP (2-20 nm). 
A synthetic strategy, often used in literature, consists in using amino-functionalized 
silica coated magnetic nanoparticles (APTES is used as precursor for silica shell). 
Citrate stabilized gold nanoparticles, with their negative charges, are electrostatically 
attracted by –NH3+ groups leading to formation of FeOx@SiO2@Au core-shell-
satellite structures (Figure 1.25a).109-111 
Another strategy involves the use of positive charged polymers instead of a silica 
coating (Figure 1.25b). 
Also small molecules can serve as linker between the iron oxide core and satellite 
gold nanoparticles. For example, the carboxylic group of the amino acid lysine can 
be coupled to FeOx core. The residual free exposed amino groups serve as 
attachment site for in situ formed gold nanoparticles in the presence of HAuCl4 and 
NaBH4 (Figure 1.25c). 
Better stability of core-shell-satellite structures has been observed when, instead of 
electrostatic coupling between shell and AuNPs, a stronger covalent bond is present. 
In this case aminoacid cysteine was used to couple with the core, followed by gold 
reduction with ascorbic acid.111 
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Figure 1.25 Three different ways to produce core-shell-satellite structures via 
electrostatic interactions: (A) amino-functionalized silica; (B) polymer coating; (C) 
lysine coating. 
 
In this thesis, core-shell-satellite nanoparticles are synthetized using thiol 
functionalized silica (MPTMS). This strategy provides strong binding between the 
gold nanoparticles and the shell via Au-S bond. Previous studies demonstrated that 
with MPTMS the shell surface coverage by gold nanoparticles is as high as with the 
amino functionalized precursor (Figure 1.26).112 
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Figure 1.26 TEM images of silica nanoparticles after reaction with gold 
nanoparticles. The silica nanoparticles were functionalized with (a) 100% 
AEAPTMS (N-(2-aminoethyl)-3-aminopropyltrimethoxysilane), (b) 100% MPTMS, 
(c)100% DPPETES (2-(Diphenylphosphino)ethyltriethoxysilane), and (d) 
unfunctionalized. All scale bars are 10 nm. 112 
 
Core-shell structures 
Core-shell structures are different from core-shell-satellite because, in this case, the 
metallic core is completely covered by the shell. Core is, teherefore, less exposed and 
the surface area to volume ratio become smaller with respect to core-shell-satellite. 
Structures like Au@FeOx core-shell particles are seldom investigated due to 
inactivated properties of Au core inside the iron oxide shell. 
More frequent and useful are FeOx@Au core-shell nanoparticles because chemical 
and optical properties of gold are still active after the synthesis. 
Two principal routes are available for the synthesis: the use of prefabricated core-
satellite nanoparticles with subsequent gold reduction and direct reduction on iron 
core. In the first one, gold satellite nanoparticles on iron oxide cores serve as 
nucleation sites for the reduction of the Au shell with Au3+ and a reducing agent. 
Different reducing agents can be used and varying the proportions between gold 
seeds and HAuCl4 the shell thickness can be varied. The other route involves the 
direct formation of gold shell on the iron oxide core. For this, the iron oxide core has 
to be modified with some functional groups that serve as template for Au nucleation. 
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A common route is to synthetize magnetite nanoparticles by reduction of Fe(acac)3 in 
presence of oleylamine and oleic acid stabilizers and then perform a typical gold 
reduction. Just formed magnetite nanoparticles acts as nucleation centers for gold 
and oleylamine provides the functional groups for adsorbing Au3+ ions.111 
Apart these two, several other methods are available for the synthesis of FeOx@Au 
core-shell nanoparticles. Some of them are listed in table 1.8. 
 
Table 1.8 List of different reaction conditions for synthesis of FeOx@Au core-shell 
nanohybrids.111 
 
Aggregates 
FeOx-Au aggregates are structures in which iron oxide and gold nanoparticles are 
randomly organized in space. With respect to the other magneto-plasmonic 
typologies, aggregates are simpler to synthetize although some polydispersion can be 
observed. 
A method to obtain aggregates with some control on the dimensions is that of 
including AuNPs and FeOxNPs within polymers. An interesting example is found in 
the work by the group of Liz-Marzàn where they were able to co-encapsulate gold 
nanostars (AuNS) and small iron oxide nanoparticles using poly(styrene)-block-poly-
(acrylic acid) (PS-b-PAA).113 First, they separately synthetize iron oxide 
nanoparticles and gold nanostar using a chemical route. Then, when water is added to 
a THF mixture of FeOxNPs, AuNS and polymer, the aggregates form (Figure 1.27). 
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Figure 1.27 Scheme of encapsulation process for FeOx-Au aggregates forming (left) 
and TEM images at different magnification of aggregates (right).113 
 
The synthesis of magneto-plasmonic aggregates made of gold and iron oxide 
spherical nanoparticles is the object of this thesis. Instead of using polymer or 
chemicals to form aggregates, the driving force involved in our synthesis was the 
different electrostatic charges of FeOxNPs and AuNPs.31 This methods allow to 
obtain nanostructures without extraneous molecules and, therefore, simple to 
functionalize.  
 
Other magneto-plasmonic structures 
Multi-layer plasmonic nanostructures are a sort of core-shell structures, but with 
more than two layers of materials.  
As stated above, silica is a common coating for iron oxide nanoparticles. A frequent 
multilayer nanostructures consists on an iron oxide core surrounded by a silica shell 
on which, in turn, gold deposition is performed forming the third layer 
(FeOx@SiO2@Au).  
Another morphology is FeOx@Au@SiO2 in which satellite gold nanoparticles are 
linked to the iron oxide core and then the whole system is covered with silica. In this 
case, silica stabilizes the core-satellite structure. Dyes can be embedded in the silica 
matrix to obtain SERS effect and/or fluorescent nanoparticles. 
Reaction scheme for these two multi-layer structures is shown in figure 1.28. 
Chapter 1 
65 
 
Figure 1.28 Scheme for the synthesis of magneto-plasmonic multi-layer 
nanostructures.111 
 
Another less used but interesting morphology is the so called dumbbell 
nanoparticles. This system is composed of one iron oxide nanoparticle and one gold 
nanoparticle, bonded together. Two strategies are commonly adopted: the first 
consists in deposit one iron oxide nanoparticle on one previously formed gold 
nanoparticle, in the second the two nanoparticles are formed at the same time. 
Evolutions of dumbbell nanoparticles are nanoflowers. Here one gold nanoparticle is 
surrounded by more iron oxide nanoparticles (from 1 to 4). Figure 1.29 shows few 
reactions for synthesis of dumbbell nanoparticles and conformation of nanoflowers. 
 
 Figure 1.29 Synthesis of dumbbell nanoparticles (left) and nanoflowers (right).111  
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The synthesis of these magneto-plasmonic materials is not simple because reaction 
times and proportions between reagents need to be carefully controlled.111 
In figure 1.30, TEM images of different kinds of magneto-plasmonic materials are 
reported to have a better view of what they are. 
 
Figure 1.30 Representative TEM images of: core-shell-satellite 
Fe3O4@polyaniline@Au nanoparticles using polymer as shell (A and B); 
FeOx@SiO2@Au core-shell-satellite nanoparticles (C); FeOx@SiO2@Au core-shell-
shell nanoparticles (D and E); polymeric aggregates of FeOxNPs and AuNPs (F).111 
 
Magneto-plasmonic nanosystems like dumbbell nanoparticles or nanoflowers are 
interesting because denote the technical and synthetic advances in the control of 
nanostructured materials.  
However, in the design of magneto-plasmonic nanosystems for biomedical 
applications an efficient but simpler system is sometimes preferred with respect to a 
sophisticated but less efficient one. 
Dumbbell, nanoflowers, nanoroses and multilayer magneto-plasmonic structures are 
representative classes of nanotechnological development approaches. However, at 
present, literature on nanotechnology cancer research seems to be more oriented on 
core-shell or core-shell-satellite structures.  
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Important goals of nanotechnology in cancer research are active tumor targeting 
nanostructures to obtain easy diagnosis, drug delivery and nanoparticle mediated 
thermal therapies. These aims can be achieved with magneto-plasmonic systems with 
core-shell and core-shell-satellite configurations because: 
1. Their synthesis is relatively easier and well established than other magneto-
plasmonic systems. 
2. Magneto-optical properties can be well controlled with simple variations of 
the reaction scheme. 
3. Less complicated reactions and reproducibility make them more suitable for 
large-scale productions. 
One last consideration concerns the use of toxic or potentially toxic chemicals during 
the synthesis. Core-shell and core-shell satellite usually requires less synthetic 
passages than others more complicated structures and this, often, means that the 
number of used chemicals is restricted. However this is not sufficient to ensure 
complete non-toxicity when these structures reach their final biomedical use. 
For this reason, new synthetic routes, which respect also green chemistry rules, are 
now an important goal. 
One of the approaches that follow a green chemistry approach is the Laser Ablation 
Synthesis in Solution (LASiS), since one can produce stable colloidal solutions 
without using surfactants or other stabilizing molecules. 
The importance of being green: Laser 
Ablation Synthesis in Solution 
The growing interest for biomedical applications of gold and iron oxide 
nanoparticles, lead scientists to think to new synthetic strategies to avoid the use of 
toxic or potentially toxic agents usually considered for chemical syntheses. 
As widely discussed above, these nanoparticles come in contact with biological 
entities ranging from cells to organs and for this reason, every chemicals that could 
show toxic effect should be avoided. Several washings steps during synthesis are not 
sufficient to guarantee the absence of unwanted molecules in the final product 
because, apart from the procedure itself, due to the nanoparticles high surface to 
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volume ratio and reactivity, molecules could be adsorbed (chemically or physically) 
onto their surface and released in a second moment. 
Apart from laser ablation, other green synthetic methodologies for the synthesis of 
gold and iron oxide nanoparticles use plants, fungi and other microorganisms. 
Gold nanoparticles have been successfully biosynthetized using plant extracts from 
Aloe Vera 114, Camphora leaves115 and Trigonella foenum-graecum116. Fungus like 
Verticillium117 or bacteria like Pseudomonas Aeruginosa118 and Rhodopseudomonas 
capsulate119 have also been used for the synthesis of AuNPs. 
For the plant-mediated synthesis, enzymes like reductases, naphtoquinones, 
anthraquinones, polyphenols and carbohydrates are able to reduce gold ions.120 
In the case of bacteria-mediated synthesis, reductases, peptides or other proteins and 
metabolites are responsible for the reduction of gold.121 
The same substances are implicated in the formation of iron oxide nanoparticles 
using fungi like Fusarium oxysporum and Verticillium122 or bacteria like 
Magnetospirillum magnetotacticum and M. gryphiswaldense121.  
However, the use of plants, bacteria or fungi for the production of nanoparticles 
requires infrastructures and multidisciplinary technical skills which are seldom 
gathered in a single research group. 
Laser Ablation synthesis in solution can avoid also the problem of a 
multidiscipilinary research team because one doesn’t need particular skills to work 
with a laser source to perform laser ablation. 
Laser Ablation assisted Synthesis in Solution (LASiS) 
The ablation is a process of material removal from the surface of an object through 
vaporization and erosion processes. 
LASiS allows to obtain nanoparticles of different metals in different solvents (often 
water) in a relatively simple way. 
The experimental set-up consists of a pulsed laser and lenses to focus the beam in the 
proximity of a metal target immersed in a solution inside a vessel (figure 1.31). 
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Figure 1.31 LASiS for nanoparticles synthesis consists on a pulsed laser focused in 
the proximity of a metal target immersed in a solvent. 
 
LASiS is a typical top-down method since the starting material is in its bulk form. 
In LASiS method, nanoparticles are formed by the condensation of a plasma plume 
originated from the laser ablation of a metal target immersed in liquid. Usually the 
metal target is positioned out of the  laser focus to prevent local boiling of solvent. 
Mechanism of laser ablation is still object of study due to its complexity and the 
short time in which it occurs. 
Figure 1.32 shows the six fundamental passages involved in the mechanism of 
ablation by a single laser pulse. The whole process occurs in less than one 
millisecond. 
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Figure 1.32 Timeline of laser ablation process in the case of ns laser pulses.123 
 
First, laser penetrates into the liquid. At this stage of the process it is important to 
consider that solvent can absorb laser light with the result that less energy reaches the 
target. In the case of ablation using a 1064 nm laser and water as solvent the 
absorption is is negligible. To reduce the solvent absorption it is good practice to 
have not more than 1-2 cm of liquid above the target. 
When the laser pulse reaches the metal target, multiphoton absorption and direct 
photoionization occurs, leading to the detachment of the ablated material. Three 
thermal processes are involved in the detachment of material: vaporization, normal 
boiling and explosive boiling. In ordinary LASiS, with laser pulses shorter than 10-7 
s, the prevalent mechanism is explosive boiling in which the material is superheated 
above its critical temperature and expelled in the form of a plasma plume containing 
highly ionized species due to high temperature and photoionization. The plasma 
plume is accompanied by emission of light and shockwaves. 
From 10-10 s to 10-7 s the plasma plume expands and simultaneously cools down. 
When the hot material inside the plasma plume starts to cool, nucleation and growth 
of metal nanoparticles take place. The coalescence of the firsts small nuclei lead to 
the final nanoparticles. 
After 10-7 s the plasma plume is extinguished and the energy released gives rise to a 
cavitation bubble, which expands and collapses emitting a second shockwave. In the 
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last moments of laser ablation, after the collapse of the cavitation bubble (t > 10-4 s), 
nanoparticles undergo chemical surface modifications. In particular surface oxidation 
can occur at this stage when water is the solvent. 
LASiS usually produces almost spherical particles because, during nucleation and 
growth processes the system minimize its surface energy.123 
 
Three are the laser parameters involved in the entire process: pulse wavelength, 
energy and duration. 
Regarding the wavelength, the use of laser light that could be absorbed by the 
nanoparticles should be avoided because the absorption decreases the amount of 
energy reaching the target. Since gold and iron oxide nanoparticles absorb UV and 
visible light, the use of lasers in the near infrared minimize the absorptions. 
Furthermore, if nanoparticles absorb laser light they can undergo further 
modifications. In particular, depending on the photon energy, photofragmentation or 
nanoparticles melting occur. The first lead to smaller nanoparticles, the second lead 
to bigger ones. For AuNPs this happens in particular using a 532 nm laser light, 
because this wavelength is near to the maximum plasmonic resonance at 520 nm (for 
nanoparticles with  20 nm diameter).124 
Increasing of pulse energy influences the amount of ablated materials but also the 
morphology/dimension of obtained nanoparticles. Productivity increases almost 
linearly with pulse energy. With high energy pulses, multiple mechanism of material 
detachment occurs simultaneously (like fragmentation, explosion, boiling and 
vaporization) and nanoparticles with a non-homogeneous size distribution are 
obtained. Usually, with low fluences, smaller nanoparticles are obtained while high 
fluences causes the formation of bigger and irregular nanoparticles. 
The pulse duration has his effects in particular on nanoparticles size distribution. 
With ns laser pulses, like in this thesis project, the pulse and the plasma plume 
coexists for a certain time and part of the laser energy is transferred to the plasma 
plume increasing its temperature, pressure and lifetime. As a consequence melted 
drops of the target ejected in the plume have higher chance to vaporize, leading to 
more homogeneous plasma plume. After cooling, nanoparticles with sharper size 
distribution are obtained with respect to fs and ps laser pulses.123 
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Gold and iron oxide nanoparticles obtained with LASiS 
During plasma plume expansion several species can participate to chemical 
reactions. This reactivity is promoted by the presence of both solvent and metal 
excited species in the plume boundary as well as the extreme temperature and 
pression reached inside the plume (103 K and 1010-109 Pa in an ordinary LASiS). 
Gold nanoparticles synthetized with LASiS using water as solvent are well known to 
be stable for long times without the use of any stabilizing agent due to their high 
negative surface charge. This is due to a partial oxidation of the surface, of the order 
of less than 10%, caused by the ablation process itself. 
In fact, XPS and FTIR experiments have evidenced the presence of Au(I), Au(III) 
and Au-O-Au species on the surface of LASiS synthetized gold nanoparticles.123,125 
The interaction between Au-O-Au bridges and negative ions in water like hydroxyl 
and chloride are supposed to be responsible of the formations of Au-O- species 
according to following reactions: 
Au-O-Au + Cl-          Au-O- + AuCl 
Au-O-Au + OH-          Au-O- + AuOH 
The presence of chloride or hydroxyl ions in solution can therefore increase negative 
charges on AuNPs surface thus preventing their aggregation. 
Clearly, in the case of charge-stabilized nanoparticles, the ionic strength of the 
solution plays a key role in the colloid stability and one needs to find the right 
balance between salt concentration and NPs stability. 
Previous works in the laboratory in which this thesis was developed, found that this 
balance is realized when AuNPs are synthetized in a NaCl 10-5 M water solution 
because in this conditions one obtains a high percentage of spherical particles with 
dimension ranging from 15 nm to 20 nm (Figure 1.33).125 
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Figure 1.33 LASiS of AuNPs at different concentrations of NaCl. A) UV-Visible 
spectra of gold nanoparticles at different NaCl concentrations: 0M (1) 10-6M (2) 10-
5M (3) 10-4M (4) 10-3M (5) 10-2M (6) and 10-1M(7). Inset graph reports absorbance 
values for all solutions. B)Percentages of spherical nanoparticles obtained as a 
function of NaCl concentration. C) Mean diameter of obtained AuNP as a function of 
NaCl concentration.125 
 
Clearly, increasing NaCl concentration, the electric double layer collapse and 
particles aggregate and precipitate. 
With LASiS, AuNPs with diameter between 15 nm and 25 nm are obtained when the 
synthesis is performed in water while in organic solvents dimensions varies between 
5 nm and 10 nm. They are mainly spherical with low percentages of spheroids and 
with a polycrystalline structure.123-126 
Iron oxide nanoparticles are synthetized by ablating a pure Fe metal target in water. 
Also in this case reactions with water occurs. 
Fe reacts with oxygen giving a mixture of oxides like magnetite (Fe3O4), maghemite 
(-Fe2O3), hematite (#-Fe2O3) and wüstite (FeO). Fe reacts with water giving also 
amorphous hydroxides or mixed oxide-hydroxide phases. 
Iron oxide nanoparticles produced with LASiS in water consists of multiphase 
polycrystalline spherical NPs embedded in an amorphous hydroxide phase with 
dimension of ca. 25 nm. 
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FeOx NPs are mainly composed of magnetite (75%), hematite (22%), wustite (ca. 
2%) and Fe (0) (ca. 1%) and shows superparamagnetic behaviour. 
Once the amorphous phase is removed with an acid treatment, iron oxide 
nanoparticles possess charge stabilization, which varies with the pH of the solution 
(see subchapter “Iron oxide nanoparticles – Chemical properties”).123,127,128 
Laser ablated FeOxNPs, like AuNPs, can remain stable for months as a stock 
solution. 
 
Gold and iron oxide nanoparticles can be produced also in other solvents, but in this 
case, other phases can forms. As an example, figure 1.34 shows TEM images and 
phases of AuNPs and FeOxNPs synthetized with LASiS using various solvents.   
 
Figure 1.34 LASiS of Au and Fe target in different solvents lead to nanoparticles 
with different composition.123 
 
To conclude this brief outlook on laser ablation synthesis in solution, some pros and 
cons of this technique are reported. The main pros are: 
1. LASiS allows to obtain nanoparticles of different materials in different 
solvents simply changing the metal target. The set-up remains the same and 
usually only minimal variations of parameters are required. Due to its 
versatility, there are few companies providing customized nanoparticles 
produced by LASiS.129 
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2. LASiS method does not necessarily require the use of chemicals and wastes, 
if any, are minimal. For this reason is a sustainable method which also 
respects green chemistry principles. 
3. Since the set-up is minimal and no expensive chemical are used, it can be 
considered a low-cost method. Manual operations are also significantly 
reduced with respect to chemical methods. These features facilitate also the 
reproducibility of the synthesis. 
4. One-step functionalization is possible either in situ (during the ablation) or ex 
situ (after the synthesis). 
5. The absence of chemicals during the synthesis and the absence of any 
stabilizer on nanoparticles surface make LASiS the most suitable method for 
the production of nanoparticles for biomedical applications. 
However, LASiS has also its cons: 
1. Although gram scale production has been reported 130, such productivity is, at 
the moment, not comparable with that of wet chemistry synthesis. 
2. The control of size distribution is lower than other synthetic methods and 
only spherical nanoparticles can be obtained. 
3. Since LASiS is a relatively young technique, a general procedure for 
nanoparticle production is still absent and every lab has its own procedures.  
Aim of this thesis 
The aim of this project is the synthesis, characterization and application in 
nanomedicine of magneto-plasmonic nanostructures. 
The work is divided in two parts. 
In the first one (chapter 2) magneto-plasmonic nanostructures are obtained 
aggregating gold and iron oxide nanoparticles in a nanocluster (AuFeOxNC). The 
peculiarity of these aggregates is that no chemicals are used to bond nanoparticles to 
each other and aggregation is controlled by operating on the opposite surface charges 
of AuNPs and FeOxNPs. By controlling the amount of AuNPs and FeOxNPs, 
nanoclusters with both good SERRS and superparamagnetic properties are obtained. 
To show the applicability of these nanostructures, AuFeOxNC are incubated with 
murine macrophages which, after being mixed with other macrophages, can be 
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magnetically guided in solution by sorting them in less than 10 minutes. SERRS 
analysis at single cell level demonstrates that nanoclusters are active also in 
biological environment and allows the identification of cells. 
In chapter 3, the synthesis of a different and engineered nanosystem is reported. In 
this case a magneto-plasmonic nanosystem with a core-shell-satellite (CSS) type 
architecture is obtained. This nanosystem is opportunely designed to minimize 
aspecific interactions with cells and it is functionalized with an antibody (D2B) 
specific for an antigen (PSMA) which is expressed by prostatic cancer cells. CSS 
nanostructures show also good SERRS properties thanks to gold satellite 
nanoparticles while magnetic characteristics are given by a core of iron oxide 
nanoparticles. 
Their efficiency, in targeting and selection, is shown for PC3-PIP cells, positive for 
PSMA, and compared with PC3 cells, negative for PSMA. The quantitative results 
show, at picomolar concentrations, a sensitivity of 98% and a specificity approaching 
100% with an overall accuracy of 98%. 
CSS nanostructures are then used in plasmonic photothermal treatment of cancer 
cells showing viability close to 0% for PC3-PIP cells only after few minutes of 
irradiations, while viability of equally treated PC3 cells remains unaltered. 
With these features, CSS nanostructures can be defined a complete theranostic agent. 
Moreover, both AuFeOx NC and CSS nanostructures are synthetized starting from 
laser ablated nanoparticles and, therefore, are more suitable for biomedical use 
thanks to the enhanced biocompatibility of laser ablated nanoparticles. 
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Gold and iron oxide nanoparticles 
aggregates for cell guiding and sorting 
In this chapter the synthesis of magneto-plasmonic aggregates and their application 
in cell guiding and sorting is presented. These aggregates show both plasmonic and 
magnetic properties and are obtained combining in a single nanostructure gold and 
iron oxide nanoparticles.  
AuNPs and FeOxNPs are combined in a single nanocluster (AuFeOxNC) without 
using any condensing material but only thanks to their native surface charges. 
Both gold and iron oxide nanoparticles are first separately synthetized by laser 
ablation synthesis in solution. The process itself, as explained in the introduction, 
produces charged nanoparticles. These surface charges are also responsible for the 
stabilization of the colloidal solution. 
After synthesis, aggregation of gold nanoparticles is obtained with centrifugation 
method. This is an important step because aggregation leads to the formation of hot 
spots, useful for SERS. Moreover, the absence of molecules on NPs surface enhances 
the possibility of having reporter molecules in hot spots and therefore larger SERS 
signals are obtained. Aggregation between AuNPs and FeOxNPs is controlled by 
mixing the two solutions at appropriate pH. In fact, it should be recalled that pH have 
influence on the surface charges of nanoparticles. 
In this step, varying the proportions between gold and iron oxide nanoparticles, one 
can enhance preferentially plasmonic or magnetic properties of AuFeOxNC and this 
is useful for different applications for which the nanostructures can be designed. 
The nanoclusters described in this chapter have been optimized for SERRS imaging 
of macrophage cells and macrophage guiding with a magnetic field. 
Macrophage cells will be used to show that superparamagnetic properties of 
AuFeOxNC are useful for their sorting when they are mixed with other cells. On the 
other side, plasmonic properties are useful for macrophage identification with 
SERRS effect. 
Macrophage cells are of great interest in nanomedicine1, 2 because they can migrate 
into tumor lesions. The possibility of guiding them with a magnetic field and to 
detect their presence with SERRS spectroscopy allows to exploit them as a “Trojan 
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horse”. In this way, AuFeOxNC can be delivered at tumor site, to improve tumor 
detection, and to apply hyperthermia therapy. 
Synthesis of AuFeOx nanoclusters 
Synthesis of gold and iron oxide nanoparticles via Laser Ablation 
Gold and iron oxide nanoparticles are separately synthetized with laser ablation 
synthesis in solution. LASiS is obtained by simply focusing laser pulses (6 ns, 50 Hz, 
1064 nm) of a Nd:YAG (Quantel Brilliant 50) on a pure (99,999%) gold or iron plate 
under water at room temperature and pressure. 
Pulses with a fluence of 1.2 J cm-2 are used to obtain gold nanoparticles in a dilute 
NaCl (10-5 M) solution in double distilled (dd) water. Sodium chloride stabilizes the 
colloidal solution (see also subchapter “The importance of being pure: Laser 
Ablation Synthesis in solution” in introduction), but it is also one of the components 
most present in biological environments. 
For iron oxide nanoparticles, fluences of 1.5 J cm-2 were used and the synthesis is 
performed in pure dd water. 
As discussed previously on the introduction, iron oxide nanoparticles obtained with 
LASiS possess a small fraction of amorphous hydroxides. The amorphous fraction is 
removed in a post-synthesis phase using a procedure developed in the hosting 
laboratory.3 HCl was added to a 0.024 M final concentration and then the solution 
was heated at 60° C for 60 minutes under constant stirring and then stored. The 
acidic pH of the solution was neutralized in a second moment during the assembling 
with AuNPs (see below), using NaOH. Total iron concentration was determined 
using o-phenanthroline method.4 Briefly, iron oxide nanoparticles (0.5 mL) are 
dissolved with 2.5 µL of concentrated H2SO4 at 90°C for 1h. Then pH is adjusted at 
about 4.5 with NaOH 0.03 M and 1 mL of acetic acid/sodium acetate buffer (pH 4.5) 
is added. 50 µL of 0.1 g mL-1 hydroxylamine hydrochloride are added to reduce 
Fe(III) to Fe(II). After 10 minutes, 250 µL of a 1 mg mL-1 of o-phenanthroline 
solution and acetic acid/sodium acetate buffer solution are added to a final volume of 
5 mL. Absorbance at 510 nm gives the amount of Fe (II) using 
(NH4)2Fe(SO4)2•6H2O (Mohr’s Salt) for the calibration curve. An approximate 
concentration of iron oxide nanoparticles is calculated using magnetite bulk density 
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(hematite has a very similar density), and FeOxNP mean diameter obtained by TEM 
images.  
AuNPs size and concentration in the colloidal solution are determined by fitting their 
UV-Vis spectra with a software developed in the hosting research group.5 
Au molar concentration can be calculated using AuNPs average diameter obtained 
from the fitting and the density of the bulk material. 
 
Assembling of the nanostructures and their labeling with a SERS reporter 
AuNPs and FeOxNPs nanoclusters were obtained with different Au and Fe 
concentrations. Those useful for experiments with cells, reported here, are those with 
1:3.5 molar concentrations of Au and Fe. 
The assembling was performed using a gold nanoparticle solution with an AuNPs 
concentration of 2.9$10-9 M and Au concentration of 7.4$10-2 mg mL-1, and a 
FeOxNPs solution with a Fe concentration of 6.25$10-2 mg mL-1 corresponding to a 
FeOxNPs concentration of 2.5$10-9 M. Molar concentration of Fe has been 
determined with o-phenanthroline method and confirmed with ICP-MS 
measurements while nanoparticles concentration has been calculated considering 
FeOxNPs with a particle size distribution like the one in figure 2.1 D, obtained from 
TEM analysis of nanoparticles. 
Before proceeding with the assembling of nanoparticles, AuNPs were aggregated 
with centrifugation method in order to form the hot spots between particles. AuNPs 
were mixed with a solution of NaOH (0.01 M) in the proportions of 1:1.5 (v/v) 
respectively and then centrifuged at 12100 g for 20 minutes. Supernatant were 
removed and particles were suspended in dd water. To complete the aggregation, 
another centrifugation cycle was performed at 12100 g for 20 minutes and then, after 
supernatant removal, nanoparticles aggregates were suspended in dd H2O. 
SERRS labeling of aggregated AuNPs was performed using thiol-functionalized 
Texas Red (TR-SH) as SERRS reporter.6 800 "L of a 36 "M solution of the dye were 
added to gold nanoparticles aggregates. After 1h, AuNPs were centrifuged and 
supernatant was removed and replaced with dd H2O. 
AuFeOxNC were assembled adding dropwise FeOxNPs at pH=2 to functionalized 
AuNPs aggregates at pH=12 until neutral pH was restored. 
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In this solution, NaCl is present but it is present also in the solution that will be used 
for incubation with macrophages. After 1h, particles were centrifuged, supernatant 
was removed and AuFeOx NC were suspended in dd H2O. 
AuFeOxNC were stabilized adding bovine serum albumin (BSA) at a concentration 
of 2.7 mg mL-1. Beside stabilizing gold and iron nanoclusters, BSA is also a 
component for the incubation with macrophages. 
AuFeOxNC were left at rest for one night and then centrifuged (12100 g, 20 min) and 
dispersed in bidistilled water. 
Functionalization with methoxy polyethilene glycol thiol 5000 Da (mPEG-SH), 
which is used to give stealth properties to nanoparticles, was performed adding a 1.1 
mg mL-1 solution of the polymer to AuFeOxNC solution. 
After 3h the solution was centrifuges, supernatant was removed and AuFeOxNC 
were dispersed in dd H2O. 
Macrophage labeling and sorting 
Experiments with macrophages were performed incubating RAW 264.7 macrophage 
cells for 24h with a solution of AuFeOxNC at a final concentration of Fe, in the 
wells, of 0.18 mg ml-1. We verified that this incubation time and concentration allow 
us to perform a complete sorting in less than 10 minutes. 
After incubation time, cells were washed multiple times with phosphate buffer saline 
(PBS) solution to remove nanoclusters in excess and then collected in a vial with 
PBS. 
The magnetic cell sorting was performed in 10 minutes placing the vial in contact 
with a commercial magnetic particle concentrator (Dynal MPC-L, Invitrogen). 
Sorted cells were separated from unsorted ones and then both were deposited in two 
different polylisinate slides for 1h. For cell fixation, a 4% paraformaldehyde solution 
was added and, after 30 minutes, all slides were washed with PBS and dried. 
Instrumentation 
UV−vis spectra of the preparation were registered in a 2 mm quartz cuvette using a 
Varian Cary 5000 UV−vis−NIR spectrophotometer. For micro-Raman measurement 
we used a Renishaw inVia micro-Raman instrument with a 20× objective and the 633 
nm line of a He−Ne laser with an output power of 1.54 mW. SERS spectra in 
solution are recorded in a 2 mm quartz cuvette using a 5x objective and a He-Ne 
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laser with a power, on the cuvette, of 1.5 mW. DLS and Z spectroscopy were 
performed with a Malvern Nano ZS instrument equipped with a 633 nm He−Ne 
Laser. For transmission electron microscopy (TEM) we recorded the images at 100 
kV with a FEI TECNAI G2 microscope. The samples for TEM analysis were 
prepared by evaporating AuFeOxNC suspension mixed with a solution of PVA, to 
avoid aggregation during evaporation of the solution, on a copper grid covered with a 
holey amorphous carbon film. Metal concentrations of the final preparation were also 
determined by ICP-MS measurements performed with an Agilent Technologies 
7700x ICP-MS. Calibration solutions were prepared by gravimetric serial dilution 
from multielement standard solutions at suitable concentrations. Microwave acidic 
digestion was operated according to EPA 305 B protocol for nanoparticles7, 8 with a 
CEM EXPLORER SP-D PLUS. Flow cytometry was performed using a BD 
FACSCanto flow cytometer. 
Results 
Synthesis of gold and iron oxide nanoparticles 
The colloidal solutions of gold and iron oxide nanoparticles are stable thanks to 
surface charges arising from the ablation process itself.3, 9-11 
FeOxNPs produced by LASiS are mainly composed of magnetite, with minor 
fraction of hematite, wustite and amorphous materials.3, 10 They show good 
superparamagnetic behavior (Figure 2.1 B) and a mean diameter of 25±11 nm 
(Figure 2.1 C) with a typical distribution showed in figure 2.1 D. Z-potential 
measurements show values of about +40 mV in acidic solutions, which determines 
good stability of these nanoparticles. 
Typical UV-Vis spectra of laser ablated AuNPs is reported in figure 2.1 F and show 
a surface plasmon resonance located at 520 nm. Fitting of this spectrum with the 
Mie-Gans theory provides mean diameter, concentration and sphericity of 
synthetized AuNPs.5 In the case of the spectra in figure 2.1 F, one obtains an AuNP 
concentration of 5.2$10-9 M with 70% sphericity and a mean diameter of about 20 
nm, which is in good agreement with TEM images of AuNPs (figure 2.1E). Z-
potential measurement performed on laser ablated gold nanoparticles show values of 
more than -30 mV, which guarantees their stability in solution. 
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Figure 2.1 (A) Cartoon representing Laser Ablation Synthesis in Solution. (B) 
Magnetic response of FeOxNPs with a permanent magnet. (C) TEM image of 
FeOxNPs synthesized with LASiS (D) size distribution of FeOxNPs from TEM 
analysis. (E) TEM image of AuNP synthesized with LASiS. (F) Absorption spectrum 
of AuNP with LSPR located at 520 nm. 
 
Synthesis and characterization of AuFeOx nanoclusters 
Aggregation of AuNPs by a controlled centrifugation creates the so called hot spots, 
namely, structures in which the electromagnetic field is enhanced. Molecules within 
hot spots show SERS activity.  
Although LASiS generated AuNPs repel each other thanks to high negative surface 
charges, the high g values generated by the centrifuge are able to overcome 
electrostatic repulsive forces until Van der Waals attractive forces prevails, according 
to DLVO theory.12 
Besides gold nanoparticles aggregation, SERS performance of the nanostructures is 
improved using a SERS reporter which is in resonance with the laser excitation (we 
used in particular the laser line with wavelength at 633 nm), so these aggregates are 
optimized for SERRS. 
The SERRS reporter used in this work, Texas Red, is functionalized with a thiol 
group (TR-SH, figure 2.2 c and d), which quickly binds to the surface of gold 
nanoparticles. AuNPs aggregates functionalized with TR-SH give high SERRS 
signals (figure 2.2 e). In figure 2.2 a, TEM image of a gold nanoparticles aggregate is 
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reported. The aggregates consist of 10-20 AuNPs with an overall size of about 60-
100 nm. The UV-Vis-NIR spectra (figure 1b) show the typical two characteristics 
plasmonic peaks of aggregated gold nanostructures with one plasmon at about 520 
nm, and a broader one at 650-750 nm. 
  
Figure 2.2 AuNPs aggregates functionalized with TR-SH: (a) TEM image of gold 
nanoparticle aggregates and (b) their UV-Visible-NIR spectrum. (c) Thiolated Texas 
Red used for functionalization of AuNPs and (d) its Uv-Visible spectrum of a 36 "M 
solution. (e) SERRS spectra of labeled AuNPs aggregates.13 
 
Gold and iron oxide nanoparticles show Z-potential of opposite sign and the 
electrostatic interactions between the two types of particles drives the formation of 
AuFeOxNC. Nanoclusters can be obtained simply by mixing the two solutions. 
Varying molar proportions between the two nanoparticles, one can enhance either 
magnetic or plasmonic properties. We found that to obtain both good SERRS signals 
and magnetic properties, Au:Fe molar ratio must be between 1:1 and 1:3.5. 
In this work we consider aggregates with Au:Fe molar ratio of 1:3.5. 
Before mixing the two solution, NaOH at a pH=12 is added to gold nanoparticles 
aggregates. The amount of NaOH added is necessary to neutralize the acidic pH of 
iron oxide nanoparticles solution. One hour after mixing, the synthesized AuFeOxNC 
were washed and concentrated by centrifugation. 
Z-potential measurement performed on AuFeOxNC show values of about -5 mV, 
which is in agreement with the neutralization of AuNPs and FeOxNPs charges. With 
such small Z-potential, nanoclusters rapidly flocculate, but the phenomenon is 
reversible with a weak sonication. 
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Dynamic light scattering (DLS) measurements performed on AuFeOxNC show 
aggregates with average size of 150-200 nm. 
Due to the low Z-potential, these nanostructures need to be stabilized. For this 
purpose we used bovine serum albumin (BSA), because coating of the NPs surface 
with an inert protein like BSA, also used in following incubation with cells, helps to 
reduce the aggregation process significantly.14, 15 
After BSA addition, the solution is stored overnight. The next day, AuFeOxNC are 
centrifuged to remove protein in excess and suspended in PBS solution. In the last 
step one also add mPEG-SH, which saturates all available free sites, if present,  on 
gold nanoparticles. The preparation is stable for months. 
The whole procedure for the synthesis of AuFeOxNC is sketched in figure 2.3. 
 
Figure 2.3 Steps for the synthesis of magneto-plasmonic AuFeOxNC functionalized 
with Texas Red as SERRS label, BSA and mPEG-SH.13 
 
The UV-Visible-NIR spectrum of AuFeOxNC is reported in figure 2.4 a. Here one 
can observe the surface plasmon resonance peaks at 500-700 nm, typical of gold 
nanoparticles aggregates as seen before. Contribution of FeOxNPs is observed 
between 450 nm and 300 nm, where these these NPs absorbs (see inset graph in 
figure 2.4 a) and contribution from BSA and mPEG-SH can be found only below 300 
nm. 
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In figure 2.4 b, typical SERRS signals of Texas Red are shown. Comparing 
intensities of the peaks with those on figure 2.2 e, one can see that intense signals are 
present also in AuFeOx NC, confirming that hot spots of AuNPs are conserved also 
when assembled with iron oxide nanoparticles. 
One representative TEM image of AuFeOxNC is shown in figure 2.4 c where one can 
see how gold nanoparticles (the darker ones) and iron oxide nanoparticles are 
arranged within a nanocluster.  
Z-potential measurement performed on BSA and mPEG-SH functionalized 
AuFeOxNC showed values of -5mV, like for uncoated nanoclusters. This highlights 
the importance of BSA and mPEG-SH coating for the stabilization of AuFeOxNC. 
 
Figure 2.4 (a) UV-Vis-NIR spectra of synthetized AuFeOxNC functionalized with 
TR-SH, BSA and mPEG-SH. Inset graph show absorption of FeOxNPs in acidic 
solution and explain small wavelength absorption of AuFeOxNC. (b) SERRS spectra 
of AuFeOxNC+TR-SH+BSA+mPEG-SH showing typical Texas Red peaks. (c) TEM 
image of AuFeOxNC.13 
 
To investigate the magnetic properties of AuFeOxNCs the solution was placed in the 
proximity of a NdFeB permanent magnet (figure 2.5 a), monitoring the variation of 
the absorption spectrum of the solution in time. 
For this purpouse, a quartz cuvette with 10 mm optical path is filled with AuFeOxNC 
solution and placed in proximity of NdFeB magnets. The cuvette with magnets is 
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placed inside a UV-Visible spectrometer and the first spectrum was recorder at the 
initial state (t = 0). As the time increase the absorbance decreases due to particles 
migration toward the magnets. At time t = t1/2 the absorbance is half of its initial 
value, meaning that half of AuFeOxNC have been attracted to magnets (figure 2.5 b). 
Monitoring the absorbance at 450 nm, spectra were collected every 5 minutes for 200 
minutes (figure 2.5 c). Absorbance at 450 nm was chosen because both gold and iron 
oxide nanoparticles absorbs at this wavelength. In less than 100 minutes, almost all 
AuFeOxNC are attracted to magnets, as can be observed in figure 2.5 c.  
Comparing the three spectra taken at times t = 0, t = t1/2 and t = 200 min (figure 2.5 
d), one can conclude that the assembling of gold and iron oxide nanoparticles 
occurred for all the nanoparticles. 
Figure 2.5 (a) Picture showing the response of AuFeOxNC when a magnetic field 
gradient is applied. (b) A 10 mm quartz cuvette in contact with magnets is filled with 
AuFeOxNC. As the time increase, the absorbance decreases due to particles 
migration. (c) Graph showing absorbance at 450 nm versus time. Spectra are 
collected every 5 minutes for 200 minutes. (d) Graph reporting spectra of 
functionalized AuFeOxNC in three representative moments of their migration: the 
beginning of the experiment (t = 0, black spectra), when absorbance is half of the 
initial one (t = t1/2, red spectra) and when all particles have been attracted (t = 200 
minutes, green spectra).13 
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In fact, in these spectra, one can see absorptions of gold and iron oxide nanoparticles 
decreasing in the same proportions, as time increases. This shows that in all the 
attracted nanoparticles there were both magnetic and plasmonic nanoparticles. 
The magnetophoresis of iron oxide nanoparticles in liquid is strongly dependent on 
nanoparticle sizes. In particular, bigger nanoparticles migrate toward magnets faster 
than smaller ones.16 The same considerations can be made for AuFeOxNC where 
faster kinetics, with lower t1/2, were observed with larger aggregates containing more 
iron oxide nanoparticles. 
 
In vitro application 
Since AuFeOx NC showed good magnetic and SERRS properties, we considered the 
possibility to load murine macrophage cells type RAW 264.7 with the nanoclusters. 
As recalled above, macrophages loaded with a magneto-plasmonic system like 
AuFeOxNC can be used for theranostic application. 
We first incubated machrophages with AuFeOxNC (figure 2.6 a). 
 
Figure 2.6 Scheme with experimental passages for machrophage labeling and 
sorting. First machropages are incubated with AuFeOxNC (a) and then sorted (b). 
When focusing a 633 nm laser on a single cell, Raman spectra of TR-SH is obtained, 
confirming the internalization of AuFeOxNC (c).13 
 
In order to obtain a population of cells with a satisfactory particles loading, cells 
were sorted for 10 minutes using a commercial magnetic particle concentrator (figure 
2.6 b) and deposited on a glass slide. 
SERRS analysis were performed on single cells (figure 2.6 c) using 633 nm laser line 
with an output power of 1.54 mW and 20× magnification. Spectra on more than 100 
cells were acquired looking for the most intense signal of Texas Red at 1505 cm-1. 
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Histogram in figure 2.7 shows signal intensities distribution at 1505 cm-1 vs number 
of cells.  
The presence of TR-SH Raman signals in all sorted cells confirms the uptake of 
AuFeOxNC and that nanoclusters show stable SERRS signal also after their inclusion 
within cells. 
To show that quantitative cell guiding using a magnetic field is possible, we 
performed an experiment in which AuFeOxNC loaded macrophages were sorted after 
being mixed with non-treated macrophages.  
After 24 hours incubation with nanoclusters, cells were washed multiple times with 
PBS and treated with carboxyfluoresceinsuccinimidyl ester (CFSE), a fluorescent 
vital dye.  
 
Figure 2.7 Histogram showing signal intensities distribution vs number of cells. The 
TR-SH signal was detected in all cells confirming the presence of functionalized 
AuFeOxNC inside the cells.13 
 
Then, NC loaded and stained cells were mixed in equal proportions with other 
macrophage cells which had not undergone any treatment. 
Flow cytometry analysis is used to determine the percentage of the two populations 
of cells in the mixed solution. Figure 2.8a show flow cytometry with relative 
percentages of treated and untreated cells before the magnetic sorting. 
The solution containing the mixed cells is then placed in the proximity of a 
commercial NdFeB particle concentrator for 10 minutes in order to separate NC 
loaded and stained cells. 
Flow cytometry shows that 95.6% of cells incubated with AuFeOxNC were 
magnetically sorted (Figure 2.8b), while unsorted cells were found to be those 
untreated (Figure 2.8c). 
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We verified also that the small amount of unsorted cells is due to mechanical mixing 
occurring during magnetic separation. 
This experiment highlights the efficiency of AuFeOxNC in magnetic cell guiding in a 
solution where other cells were presents. 
It should be noted that usually such magnetic efficiency is obtainable with 
commercial magnetic beads with sizes in the order of micrometers. In this case, 
AuFeOxNC aggregates have sizes between 150-200 nm, notably smaller with respect 
to commercial ones. 
 
Figure 2.8. Performance evaluation of magnetic cell sorting by flow cytometry. (a) 
RAW 264.7 macrophages incubated with AuFeOxNC and marked with fluorescent 
label CFSE mixed in equal proportion with untreated macrophages. (b) Flow 
cytometry showing that 95.6% of magnetically sorted cells were those incubated 
with AuFeOxNC. (c) Flow cytometry of unsorted cells shows that macrophages 
treated with AuFeOxNC are practically absent.13 
 
Furthermore, AuFeOxNC showed good labeling properties thanks to high SERRS 
signals. SERRS measurements showed that typical TR-SH signals were present on 
sorted cells.13 
Conclusion 
Magneto/plasmonic nanostructures are of particular interest in nanomedicine because 
allows cell manipulation and identification using only one system. However, their 
synthesis is often complex and require more passages with several purification steps 
due to chemicals required for synthesis.  
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In the present case, AuFeOxNC are synthesized from laser ablated gold and iron 
oxide nanoparticles and assembled exploiting the different surface charges of the two 
nanoparticles. 
The absence of chemicals to stabilize just synthetized nanoparticles or to assemble 
the nanoclusters makes AuFeOxNC simple to produce and suitable for use in 
nanomedicine. 
Magnetic and plasmonic properties can be tuned depending on the needs simply 
changing molar proportions between nanoparticles. TEM images and DLS 
measurements show nanoclusters with dimensions between 150 nm and 200 nm. 
We observed that SERRS and magnetic properties of the nanoclusters were 
maintained also after the assembling and use for cell manipulation. Micro-Raman 
measurement performed at single cell level showed high SERRS signals, confirming 
the possibility to perform imaging on sorted cells. FACS experiment showed that up 
to 95% of cells incubated with AuFeOxNC can be sorted in solution in less than 10 
minutes.  
The work presented in this chapter has been published in 2014.13 
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FeOxNP@dye-doped Silica@AuNP 
Core-Shell-Satellite nanostructures 
In chapter 2 the synthesis and in vitro application of AuFeOx nanoclusters was 
shown. Thanks to a good internalization in machrophage cells, an efficient magnetic 
guiding and cell identification was possible. 
However AuFeOxNC suffers of some limitations for their use with cells. In 
particular, the absence of targeting ligands (like antibodies) does not allow the 
selection of cells and their identification. 
With macrophages a targeting ligand is not necessary because their biological 
function is to engulf particles, debris, foreign substances, cancer cells etc. that could 
be present in blood and for this reason AuFeOxNC in solution are easily phagocyted. 
However, aim of this thesis is the synthesis of nanostructures for magnetic sorting of 
specific cancer cells and their photothermal treatment. To achieve this goal with a 
nanostructure, the use of targeting ligands is necessary.  
The use of antibodies in nanostructures for active targeting techniques has been 
widely discussed in the introduction of this thesis.  
After the experiment with macrophages we tried immunomagnetic sorting of 
prostatic cancer cells using antibody functionalized AuFeOxNC. Unfortunately, 
although antibodies were present on nanoclusters surface, the system was highly 
non-specific and both prostatic cancer cells and control cells were equally targeted. 
Non-specific interactions between nanoparticles and cells can depend on different 
parameters which are still object of study.1 
These observations lead us to think that AuFeOxNC were not suitable to perform 
immunomagnetic sorting of cancer cells, even if they were very efficient in 
macrophage guiding and imaging. Therefore, a different nanosystem, with different 
characteristics was engineered, always with magneto-plasmonic properties. 
Like in the previous chapter, here we present the synthesis of magneto-plasmonic 
nanostructures with a green approach following the green chemistry prescriptions 
and based on the laser ablation of bulk materials in water at room temperature and 
pressure. The synthesis proceeds with the assembling of the nanoparticles to produce 
FeOxNP@dye-doped Silica@AuNP-Ab a core-shell-satellite (CSS) structure with a 
core of magnetic nanoparticles, a shell of silica and gold nanoparticles as satellite. 
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Then, the CSS are functionalized with D2B antibodies (CSS-Ab) for the targeting of 
the PSMA prostate specific membrane antigen which is overexpressed on prostatic 
cancer cells.  
Unlikely AuFeOxNC, in this case the coupling of magnetic and plasmonic 
nanoparticles has been faced by covering the magnetic nanoparticles with a silica 
shell exposing thiols on its surface and to which gold nanoparticles are quickly 
linked. This method also allows to better control the morphology of the as 
synthetized nanostructures.  
In the silica shell a SERS reporter is included and its interaction with the gold 
nanoparticles makes the nanostructure also a very efficient SERS active probe.  
A targeting activity of the nanostructures opens better perspectives both for imaging 
and therapeutic purposes. In these cases one needs also a further effort for a 
quantitative determination of the targeting activity in particular as a function of the 
concentration of the nanostructures, which is not usually available in literature. 
Here we show quantitative evaluation of the targeting activity of antibody 
functionalized CSS nanostructures with PSMA positive and negative cells, exploiting 
their magnetic and SERS activities. Results show a very good targeting activity of 
the nanostrutures with an overall targeting accuracy of 98% at picomolar 
concentrations. 
Furthermore, we will show how CSS-Ab can be efficiently used for photothermal 
treatment of prostatic cancer cells. Different experimental approaches have been 
designed to prove their efficiency. Photothermal treatment is exploited using the 
plasmonic properties towards the NIR of gold nanoparticles present as satellites on 
the structure.  
The last section of this chapter reports the efforts in tuning the plasmonic peaks to 
longer wavelenghts, namely toward 900-1000 nm because this spectral region is 
more appropriate to perform plasmonic photothermal therapy. 
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Synthesis of Core-Shell-Satellite 
nanostructures 
Synthesis of gold and iron oxide nanoparticles 
Gold and iron oxide nanoparticles were synthesized according to the protocols 
already reported in chapter 2. The procedure was only modified for the amorphous 
phase removal in the synthetized iron oxide nanoparticles. In this case another 
cleaning procedure was performed by adding disodium EDTA at a final 
concentration of 9.4 mM.2, 3 After the addition, nanoparticles were maintained at 
60°C for 1h under constant stirring and then washed several times with dd water after 
centrifugation cycles at 3700 rcf. This protocol variation was used because we 
experimentally observed that a more homogeneous silica shell is formed, in the 
following synthetic step, when FeOxNPs are cleaned with ETDA and not with HCl. 
However, differences in FeOxNPs morphology and size following the two protocols 
were not observed.  
Assembling of antibody functionalized core-shell-satellite (CSS-Ab) 
nanostructures 
The second step of the synthesis produces the Core-Shell nanostructures (CS), with a 
core of FeOx and a shell of silica. The silica shell was synthetized using 3-
mercaptopropyl trimethoxysilane (MPTMS, Sigma-Aldrich), as precursor, in a 
modified Stöber synthesis.4 5 mL of FeOxNPs (4.3 nM) were centrifuged, suspended 
in ethanol and mixed with 5 mg of MPTMS, 200 "L of dd H2O, 125 "L of NH4OH 
30% and 5 mg of crystal violet (Sigma-Aldrich) as SERS reporter. In this case one 
can call the dye a SERRS (surface enhanced resonance Raman scattering) reporter 
since the spectra are recorded exciting at 633 nm, in resonance both with the 
localized plasmon resonance and the dye. The mixture was kept under vigorous 
stirring for 6 h at room temperature to obtain the CS nanostructures. The CS 
nanostructures were magnetically separated and washed four times with dd water and 
dispersed in 1 mL of phosphate buffered saline (PBS) solution in the last step.  
The third step of the synthesis produces the core-shell-satellite (CSS) structures with 
AuNPs as satellites. 
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The strong linking of AuNPs to the silica shell is made possible by the presence of 
the thiol groups on the silica shell. The CSS synthesis was obtained by simply 
mixing the colloidal solution of AuNPs with CS nanostructures in PBS, and 
magnetically collecting the CSS nanostructures. 
The presence of PBS or, more generally, a solution with high ionic strength is crucial 
in this step of the synthesis. In fact, both CS nanostructures and AuNPs are 
negatively charged at neutral pH. Z-potential measurements show values ranging 
from -35 mV to -40 mV for CS nanostructures and a value of -40 mV for AuNPs.  
A negative surface charge of the silica coating of CS is present because, in addition 
to –SH functional groups, there are Si-OH terminal groups that are partially 
deprotonated at a pH=7 in water.5 The use of physiological PBS buffer helps to 
screen the negative charges for the large concentration of Na+ cations so the two 
different particles can binds to each other.6 
In practice, the CS solution was mixed with 15 mL of AuNPs solution (6.4 nM), 
placed in a sonication bath for 30 minutes and then in proximity of a permanent 
magnet in order to separate core-shell-satellite nanostructures (CSS) with gold 
nanoparticles linked to the CS nanostructures, from nanoparticles with only AuNPs. 
Finally, CSS were washed, using three centrifugation cycles, and dispersed in 1 mL 
of PBS. In order to avoid the reactivity of remaining thiols groups on the CS surface, 
0.1 mg of methoxy-polyethyleneglycol-maleimide (mPEG-MAL, Laysan Bio, 5000 
Da) were added to the solution to block all the remaining free thiol groups. The CSS 
nanostructures were washed again with PBS, by three centrifugation cycles, and 
finally dispersed in 1 mL of PBS. The SERRS signals of the nanostructures were 
found to be strong and stable in time.  
The fourth step of the synthesis corresponds to the functionalization of the CSS 
nanostructures with the D2B monoclonal antibody, specific for the PSMA antigen, to 
obtain CSS-Ab.  
D2B was first functionalized with thiol groups (D2B-SH) by reacting the ammine 
groups of the lysine side chains with 2-iminothiolane (2-IT) accordingly to a 
previous published protocol.7 Briefly, functionalization was performed in PBS 
solution with 10% v/v NaHCO3 1 M and using a D2B to 2-IT molar ratio of 1:10. 
Reaction was kept at room temperature under vigorous stirring for 2h and then 
overnight at 4°C. Then, the functionalized antibody was purified from reaction 
Chapter 3 
115 
 
products using 5000 Da concentrators (Sartorius) and rinsed with PBS. The success 
of the functionalization was determined with a spectrophotometric measurement of 
the thiol groups using 4,4’-dithiodipyridine.8 Performing the test on the 
functionalized D2B antibody, and using pristine D2B as control, we measured an 
increment, on average, of about 1 thiol per antibody.  
Functionalization of CSS with the antibody was performed adding 0.800 mg of 
functionalized D2B-SH to 1 mL of the CSS solution. Solution was stirred for 6 h at 
room temperature and then stored overnight at 4°C. CSS-Ab solution was then 
centrifuged and rinsed with PBS to remove unreacted antibody, and finally dispersed 
in 1 mL of PBS.  
The estimation of the amount of antibody conjugated to the aggregates, was obtained 
by comparing the absorbance at 280 nm of the initial D2B-SH solution with the 
supernatant solution after the cleaning centrifugations and it shows that about 300 
antibodies are present on average for each CSS-Ab structure, namely about one 
antibody per AuNP (see below for the characterization of the nanostructures).  
To complete the synthesis and add stealth properties to the CSS-Ab nanostructures, 
0.01 mg of methoxy-polyethylene-glycol-thiol (mPEG-SH, Laysan Bio, 5000 Da) 
were added to the solution of CSS-Ab. mPEG-SH was added also to saturate all 
available linking sites on gold nanoparticles. 
After 15 minutes of reaction, in a sonication bath, CSS-Ab nanostructures were 
magnetically collected and dispersed in 1 mL of PBS.  
The whole synthesis procedure is sketched in figure 3.1. 
 
Figure 3.1 Steps of the synthesis of FeOxNPs@dye-doped Silica@AuNPs-Ab core-
shell-satellite (CSS) nanostructures and their conjugation with D2B antibody (CSS-
Ab). 
 
The presence of the Ab on the CSS-Ab was confirmed by flow cytometric 
measurements with a BD FACSCanto flow cytometer. CSS-Ab were incubated with 
a fluoresceine-labeled goat anti-mouse antibody (GAM-FITC, see figure 3.5 in the 
characterization section), and after some washing steps, the aggregates were 
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analyzed by flow cytometry. For reference, flow cytometry analysis was also 
performed only on CSS nanostructures not incubated with GAM-FITC. 
The D2B activity on CSS-Ab for PSMA present on cells was obtained with a flow 
cytometry analysis using PC3-PIP. Cells were incubated with CSS nanostructures 
and then, after two washing steps, with GAM-FITC to stain NPs linked to cell 
surface. A positive control, prepared only with D2B antibody, before the GAM-FITC 
staining, and a negative one using only GAM-FITC without CSS-Ab or D2B, were 
also analyzed. The same measurements were performed on PC3 cells that do not 
express the PSMA antigen (see Figure 3.6 in the characterization section). 
Au and Fe concentrations in final preparations were determined with an ICP-MS 
Thermo Elemental, X7 Series equipped with the PlasmaLab software. Using 
nanoparticle mean diameters, obtained by TEM images for FeOxNPs and fitting of 
the localized surface plasmon spectra for AuNP, and the bulk densities, of the two 
materials, one estimates a AuNPs concentration of 23 nM and FeOxNPs of 6 nM, 
namely a ratio of 3.8.  
The concentration ratio of the two types of atoms was also confirmed by EDX 
measurements performed with a JSM Jeol 6490 SEM-EDX microscope at 20 kV.  
CSS-Ab structure concentration in final preparation is estimated to be 89 pM. This 
concentration was obtained by dividing the total number of FeOxNPs in solution by 
the average number of FeOxNPs present in a single core-shell particle evaluated by 
examining about 30 TEM images like that in Figure 3.2A. 
Experimental procedures concerning the use of CSS-Ab for immunomagnetic sorting 
and photothermal treatment of cancer cells are described in the experimental part. 
Characterization of antibody functionalized core-shell-satellite 
(CSS-Ab) nanostructures 
Instruments and techniques for the characterization of CSS-Ab nanostructures 
Intruments and techniques are those already reported for the synthesis and 
characterization of AuFeOxNC (see pag. 92). 
Characterization 
The characterization of AuNPs and FeOxNPs made by laser ablation synthesis in 
solution is reported in subchapter “Results” of chapter two. 
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Figure 3.2A shows a representative TEM image of the CS nanostructures where the 
FeOxNP are seen as darker particles inside the structure.  
 
 
Figure 3.2 TEM images of (A) FeOxNPs@dye-doped Silica core-shell (CS) 
nanostructures and (B) FeOxNPs@dye-doped Silica@AuNPs core-shell-satellite 
(CSS) nanostructures. (C) Size distribution of CSS nanostructures from TEM 
images. (D) UV-Visible-NIR absorption spectra of FeOx NPs@dye-doped Silica 
(CS) (black line) and FeOx NPs@dye-doped Silica@AuNPs (CSS) nanostructures 
(red line) in water. (E) Raman spectrum of CS nanostructures (black) and SERRS 
spectrum of crystal violet obtained with CSS structure in water (Laser= 633 nm). (F) 
UV-Visible spectra of an aqueous solution of Crystal Violet and its molecular 
structure. 
AuNPs are linked to the CS nanostructures to obtain the final core-shell-satellite 
(CSS) nanostructures.  
After AuNPs binding to CS, the overall Z-potential sets at about -30 mV. This value 
was maintained also after conjugation with antibodies, mPEG-MAL and mPEG-SH 
(see below). This is a good value for stability of nanostructures in solution and 
allows reducing unspecific interactions with cells. 
The magnetic sorting was used to separate aggregates with magnetic properties from 
pure AuNP aggregates. One finds that the separated aggregates show the localized 
plasmon resonances extending in the near infrared, which is characteristic of 
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aggregated gold nanoparticles. Figure 3.2B shows a TEM image of a characteristic 
CSS aggregate and Figure 3.2C their size distribution. Other CSS TEM figures are 
available in figure 3.3. CSS mean diameter results to be 368±159 nm, which was 
confirmed by a Z-average value of 437 nm obtained with a DLS analysis.  
 
Figure 3.3 Additional TEM micrographs of CSS-Ab nanostructures. 
All residual thiols on the silica shell were saturated with methoxy-
polyethyleneglycol-maleimide that prevents any residual unwanted reaction of the 
thiol groups. This is important also for the control of the interaction with cells.   
CSS composition is obtained with an EDX measurement and shows, by weight, 84% 
Au and 16% Fe (see Figure 3.4).  
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Figure 3.4 EDX measurement performed on a sample of FeOxNP@dye-doped 
Silica@AuNPs core-shell-satellite (CSS) nanostructures. 
 
Considering that, on average, are present AuNPs of 20 nm and FeOxNPs of 25 nm, 
one obtains a ratio of AuNPs/FeOxNPs of 3.5. This value is in good agreement with 
the ratio of 3.8 obtained from the concentrations of Au and Fe obtained from ICP-
MS analysis. The absorption spectrum of CSS nanostructures in water is reported in 
Figure 3.2D (red line) and shows a broad band from 500 nm to 750-800 nm. 
Compared with the absorption spectrum of the CS nanostructures without satellite 
AuNPs (Figure 3.2D, black line), in which also the crystal violet absorption peak is 
clearly visible at about 600 nm, one finds that the AuNPs contribution is observed as 
a broad absorption from 500 nm to 750-800 nm, which is characteristic of aggregated 
AuNPs, as observed above.7, 9 Since the dye absorption band at 600 nm (Figure 3.2F) 
is in resonance with the laser light used for the SERS measurements at 633 nm (see 
below), CSS nanostructures are also optimized for SERRS (surface enhanced 
resonance Raman scattering) in which both the plasmon enhancement and the 
molecular resonance enhancement are present. In Figure 3.2E (red line) SERRS 
spectra of crystal violet in CSS nanostructures is reported. Although the dye 
molecules are not directly linked to the AuNPs, large signals are observed, 
comparable to those observed linking directly the molecules on the surface of 
aggregated AuNPs. Since SERS signals strongly depend on the distance between 
molecules and the AuNPs surface, the observed intensity of the signals shows that 
dye molecules are present on the surface of the CS nanostructures and that a strong 
interaction with the AuNPs is present. For comparison, one can see very small 
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Raman signals arising from CS nanostructures, in which AuNPs are not present 
(Figure 3.2E, black line). 
The D2B antibody (specific for prostate specific membrane antigen, PSMA)10 
coupling to CSS (CSS-Ab) was performed using the thiol functionalized antibody 
(D2B-SH), obtained according to the procedure described in the “Assembling of 
antibody functionalized core-shell-satellite (CSS-Ab) nanostructures” section. 
The presence of antibodies on CSS-Ab was verified with flow cytometry analysis by 
incubating the CSS-Ab nanostructures with FITC labeled goat antimouse anti-
antibody (GOAT-FITC). Results from flow cytometry analysis show the presence of 
D2B antibody on the CSS-Ab nanostructures while no FITC signal was detected in 
reference samples (Figure 3.5). 
 
Figure 3.5 Flow cytometry analysis of (A) solution of 0.2% BSA in PBS, (B) CSS 
nanostructures in a solution of 0.2% BSA in PBS (C) GAM-FITC in 0.2% BSA in 
PBS and (D) CSS-Ab incubated with GAM-FITC. Fluorescence signals are recorded 
only for sample (D) demonstrating the presence of D2B antibodies on CSS-Ab. 
 
The activity of the antibodies was assessed by incubating the CSS-Ab nanostructures 
with PC3-PIP cells, which overexpress prostate specific membrane antigen (PSMA+), 
or with PC3 cells, which do not express this antigen (PSMA-). After incubation and 
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several washing, the presence of CSS-Ab nanostructures on cells surface was 
assessed by using GAM-FITC reagent. Flow cytometry results are reported in figure 
3.6 and show that the CSS-Ab nanostructures efficiently target only PC3-PIP 
(PSMA+) cells (Figure 3.6C and 3.6F). Their target specificity is found comparable 
to that of pure D2B antibody in solution (Figure 3.6B and 3.6E). Control 
measurements show that GAM-FITC does not bind to the two cell types (Figure 
3.6A and 3.6D). The total number of antibodies present on a CSS-Ab was obtained 
by using the absorption decrease at 280 nm of the supernatant of the reaction 
synthesis (see figure 3.7). One can deduce that ca. 300 active antibodies are present 
per CSS-Ab nanostructure, namely about one antibody, on average, per AuNP. 
However, only a small number of them will be active, of the order of some %, 11 
since these large proteins can have different orientations on the surface of a 
nanoparticle, namely side-on and end-on orientation, and they can also form layers 
so that only a small number can interact with antigens on cells. 
 
Figure 3.6 Flow cytometry analysis of PC3 PIP (PSMA+) in the upper part and of 
PC3 in the lower part. Cells are incubated only with GAM-FITC ((A) and (D)), pure 
D2B and then with GAM-FITC ((B) and (E)) and CSS-Ab at a concentration of 4.4 
pM and then with GAM-FITC ((C) and (F)). The data show that CSS-Ab has an 
activity of D2B antibody similar to pure D2B and that the activity is specific for 
PSMA present on PC3PIP cells. 
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Figure 3.7 Absorption spectra of D2B solution before conjugation (black line) and in 
the supernatant (red line) after conjugation and centrifugation. 
 
Immunomagnetic sorting of cancer 
cell 
Methods 
Cell cultures 
PC3 cells are prostate human cells purchased from the American Type Culture 
Collection (ATCC, Rockville, USA) and cultured in RPMI 160 Medium (Biochrom 
GmbH, Berlin, Germany) supplemented with 2 mM L-glutamine, 10% heat-
inactivated fetal bovine serum (FBS, Lonza Swiss) and antibiotics (0.1 mg ml-1 
streptomycin and 100 units ml-1 penicillin G, Sigma-Aldrich, St Louis, MO, USA). 
PC3-PIP cells, permanently transfected with human PSMA antigen, were kindly 
provided by Dr. W. Heston (Department of Cancer Biology, Lerner Research 
Institute, Cleveland) and are widely described in the literature.12 Cells were grown in 
culture flasks and maintained in an incubator at 37 °C and 5% of CO2 under a 
humidified atmosphere. 
Cell incubation, immunomagnetic sorting and single-cell SERRS analysis 
For immunomagnetic sorting experiments, 250000 PC3-PIP (PSMA+) cells were 
incubated with increasing concentrations (1.1, 2.2, 4.4, 8.9 and 17.8 pM) of CSS-Ab 
nanostructures in a volume of 200 "L for 1 h at 4°C in the presence of 5% Bovine 
Serum Albumin (BSA) to block non-specific protein interactions. Then, the solution 
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was placed in the proximity of a commercial magnetic particle concentrator (Dynal 
MPC-L, Invitrogen) and, after 10 minutes, magnetically sorted cells were collected, 
and, separately, those which were not magnetically collected. Then, cells were 
washed with PBS solution, counted and seeded on a glass slide. After cell adhesion, 
cells were fixed by a 2% paraformaldehyde solution for 30 minutes at room 
temperature, and then glass slides were washed, rinsed in water and dried.  
SERRS measurement of each single cell were performed with a Renishaw inVia 
micro-Raman instrument using a 20x objective and, for 1s for each cell, 1.5 mW of a 
He-Ne laser line at 633 nm. The localization of cells and the automatic 
measurements of the spectra of all single cells was possible with a home-made 
software. Optical images of CSS-Ab on cells have been acquired with the 
microscope of the Raman spectrophotometer while FE-SEM images were performed 
with a Zeiss instrument at 3.00 kV and 10.00 kV. 
Results 
The performance of CSS-Ab in targeting and sorting of cancer cells was obtained 
with incubation with PC3-PIP cells, which overexpress PSMA (PSMA+) and with 
PC3 cells, which do not overexpress PSMA, (PSMA-) (figure 3.8). Increasing 
concentrations of CSS-Ab were used to verify how they affect the sorting efficiency. 
After an incubation of one hour, cells were magnetically sorted by placing the 
solution in the proximity of a magnet for 10 minutes and then both sorted and 
unsorted cells were collected and counted. Several hundred thousand cells were used 
for obtaining good statistical results. 
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Figure 3.8 Scheme for immunomagnetic sorting performance evaluation of CSS-Ab 
nanostructures. CSS-Ab are separately incubated with cells expressing or not 
expressing PSMA antigen. After 1h incubation the solution is placed in a magnetic 
particle concentrator for 10 minutes and then cells are counted. 
Graph in figure 3.9A shows percentages of magnetically sorted PSMA+ and PSMA- 
cells as a function of CSS-Ab concentration. For low concentrations of CSS-Ab, of 
the order of 1 pM, 60-70% of PSMA+ cells were sorted. Increasing concentrations to 
4.4, 8.9 pM, show a sorting saturation at about 90%. For PSMA- cells the unspecific 
sorting was found to be low, below 5%, for low concentrations of nanoparticles, and 
it increases to 30% for 17.8 pM, the highest explored concentration.  
The collected cells were fixed on a glass slide and their images, obtained with a 100x 
objective, allows to see the presence of the CSS nanostructures only on the surface of 
the PC3-PIP cells due to their strong scattering (see dark spots in figure 3.10). Here 
the dark spots show a variable local concentration of nanoparticles and this can be 
related to the local presence and clustering of the antigens on the cell surface. 
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Figure 3.9 (A) Percentages of immunomagnetically sorted PSMA+ (PC3-PIP) and 
PSMA- (cells) as a function of CSS-Ab concentration during incubation. (B) 
Immunomagnetic sorting of cells with a different CSS-Ab batch shows reproducible 
trends in the same concentration range.  
 
Figure 3.10 100 X Magnification images of PC3 cells (top) and PC3 PIP cells 
(bottom) incubated with CSS-Ab nanostructures. CSS-Ab nanostructures are visible 
as dark spots on PC3-PIP cells only. 
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The presence of CSS-Ab on the surface of PSMA+ (PC3-PIP cells) has been 
assessed also acquiring FE-SEM images of the cells (figure 3.11A and B) and 
confirmed with EDX analysis which show the presence of gold in the analyzed spot 
(figure 3.11 C). 
 
Figure 3.11 FE-SEM images of a PSMA+ (PC3-PIP) cell immunomagnetically 
sorted using CSS-Ab nanostructures (A) and its magnification (B) in correspondence 
of the red circle in (A). The red circle in (B) corresponds to CSS-Ab nanostructures 
as confirmed by EDX analysis on the spot (C) where clear Au signals are found.  
The reproducibility and the efficiency of the CSS-Ab in immunosorting of cells were 
verified by repeating the experiments using a second batch of nanostructures. Flow 
cytometer analyses (figure 3.12) show the same affinity to PSMA antigen of the first 
batch. 
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Figure 3.12 Flow cytometry analysis of PC3 PIP (PSMA+) in the upper part and of 
PC3 in the lower part. Cells are incubated only with GAM-FITC ((A) and (D)), pure 
D2B and then with GAM-FITC ((B) and (E)) and CSS-Ab at a concentration of 10 
pM and then with GAM-FITC ((C) and (F)). Similarly to the first batch of CSS-Ab 
(which flow cytometry analysis is shown in figure 3.6) the data show that the second 
batch of CSS-Ab has an activity of D2B antibody similar to pure D2B and that the 
activity is specific for PSMA present on PC3PIP cells. 
Results of immunomagnetic sorting with the new CSS-Ab are shown in figure 3.9 B. 
Comparing the two graphs in figure 3.9 A and 3.9 B one finds that the same trend is 
observed, with a low percentages of PSMA+ sorted cells for low concentrations of 
CSS-Ab nanostructures and the maximum (almost 100% of PSMA+ cells sorted) 
when the concentration is the largest explored 19.1 pM. The only difference is found 
in the percentage of PSMA- sorted cells which, in this last case, is found to be very 
low (<6%) for all concentrations. This suggests the presence of false positives for the 
PSMA- cell sorting with the first CSS-Ab nanostructures, probably due to accidental 
errors in the separation procedure.  
The immunomagnetic sorting efficiency and specificity is comparable with that of 
commercial products. As an example, in figure 3.13 flow cytometry of Dynabeads® 
FlowComp™ Mouse CD4 Kit is reported from the vendor website.13 This kit is used, 
for example, for immunomagnetic separation of T cells type expressing the CD4 
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antigen. Flow cytometry show that 97.2% of T (CD4+) cells can be sorted using this 
commercial kit. However no information about non-specific cell sorting is given. 
 
Figure 3.13 Flow cytometry of T (CD4+) cells using commercial antibody-
functionalized beads show efficiency comparable with that of CSS-Ab 
nanostructures.13 
The time required for sorting with the commercial beads is similar to that used with 
CSS-Ab (about ten minutes), although they are about ten times bigger than CSS-Ab. 
For beads with size comparable to CSS-Ab the vendor recommends separations with 
longer times.13 This shows that the immunomagnetic sorting with the CSS-Ab is very 
efficient. 
Furthermore, the CSS-Ab, have other characteristics which make them a more 
powerful tool. In particular, thanks to their SERRS activity, CSS-Ab nanostructures 
can be used to perform imaging on single cells. 
SERRS analysis on single cells 
The SERRS property of the CSS-Ab nanostructures makes possible multiplexed 
analyses, namely the recording, in a single spectrum, of different SERRS signals that 
can be made to correspond to different antigens. This allows analyzing many 
antigens with only one immunomagnetic sorting. In this case different CSS-Ab 
nanostructures have to be functionalized with different antibodies and different dyes. 
The feasibility of applying CSS-Ab nanostructures in imaging sorted cells was 
verified by recording their SERRS spectra after the sorting procedure.  
We deposited sorted PSMA+ (PC3-PIP) and PSMA- (PC3) cells on a glass slide and 
recorded the SERRS spectra of single cells looking, in particular, to the most intense 
band of crystal violet at 1618 cm-1. Several hundred cells have been analyzed for 
each sample.   
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The signal of crystal violet is expected only for PSMA+ cells because they should 
have CSS-Ab particles on their structure (see figure 3.14).  
 
Figure 3.14 SERRS analysis of single cells: first PSMA+ and PSMA- sorted cells 
are deposited on a glass slide and the most intense signal of the .SERRS reporter is 
registered for each cell. The signals are observed where the CSS-Ab are present. 
Results are shown in figure 3.15 A and B for the two batches of CSS-Ab together 
with the results recorded after the immunomagnetic sorting.  
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Figure 3.15 Sorted PSMA+ (PC3-PIP) and PSMA- (PC3) cells also with SERRS 
signals (green and red lines). For comparison, data from immunomagnetic sorting 
only are reported in both graphs (grey and light gray lines). (A) refers to the first 
batch of CSS-Ab as in figure 3.9A while (B) refers to the second batch as in figure 
3.9B. 
In both cases, the green line, which represents the percentage of PSMA+ cells that 
have been sorted and also show SERRS signal is superimposed to the grey lines 
representing data from immunosorting only. This means that all the sorted PSMA+ 
cells showed SERRS signal, as expected. In the case of PSMA- cells, the percentages 
of cells that also show SERRS signals (red lines in figure 3.15 A and B) is lower than 
the percentages of magnetically sorted cells. This is particularly evident in the first 
case (figure 3.15 A) where only a fraction of the sorted PSMA- present SERRS 
signal, in particular at the highest concentration. The presence of these sorted cells 
without SERRS signals only for the case of PSMA- cells, and considering that the 
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SERRS signals are very efficient, suggests that errors can be present in the 
immunomagnetic sorting, probably related to the pipetting of the cells which are not 
attracted by the magnet. This is also evident from the experiment done with the 
second batch of CSS-Ab, where this problem is not present.  
The results show, however, that the SERRS signals of CSS-Ab nanostructures are 
observed also after the sorting procedures and that the positive cells can be identified 
with the SERRS analysis.  
Multiplexed analyses have not been performed at the moment. However, as proof of 
principle we synthetized other CSS nanostructures (without antibodies) embedding 
different dyes in the shell. In figure 3.16 Raman SERS spectra of these 
nanostructures are reported, evidencing that the spectra of different dyes are easily 
distinguishable between them. This allows to foresee that the use of CSS-Ab also for 
a multiplexed analysis in multiplexing mode, which is not possible with commercial 
magnetic beads and a single immunomagnetic sorting. 
 
Figure 3.16 SERRS spectra of CSS nanostructures with different dyes (Rhodamine 
6G, Crystal Violet, Methylene Blue and Sulphorhodamine 101) embedded in the 
silica shell. Spectra are recorded exciting at 633 nm and normalized to their most 
intense peak. 
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Photothermal treatment of cancer cells 
In this section the application of CSS-Ab for photothermal treatmen of cancer cells is 
reported. As explained in the introductory section, photothermal effect is due to the 
heat generated by gold nanoparticles irradiated in resonance with their localized 
surface plasmon (LSPR). CSS-Ab nanostructures have the LSPR maximum 
absorption in the spectral range of 600-700 nm, therefore, the cells were irradiated 
using a 647 nm continuous laser wavelength. Other laser parameters to be taken in 
account in photothermal experiments are the irradiation time and the power density 
(W cm-2). The experiments were carried out by varying the irradiation time and 
maintaining constant the power density at values similar to those found in 
literature.14-18 
Before performing irradiation of the cells the temperature increase following the 
irradiation was verified embedding the CSS-Ab in an agarose hydrogel. It is in fact 
known that hydrogels, with their high water content, can simulate a biological 
environment.19 Results of the experiments are reported below, and they show a 
notable increase of temperature.  
Photothermal treatment experiments on cells have been performed using both 
PSMA+ (PC3 PIP) and PSMA- (PC3) cells with four different kinds of experiments.   
First, the effect of laser irradiation on cells non incubated with CSS-Ab verified only 
the effect of the laser on cells viability. In a second experiment PSMA+ cells were 
incubated with the CSS-Ab and the cell viability was evaluated at different 
irradiation times and at a fixed power density. 
In the third experiment, a real situation was simulated using PSMA+ or PSMA- cells 
incubated with CSS-Ab to evaluate the photothermal effect in a situation as close as 
possible to a real one. 
In the fourth experiment the so called “bystander effect”, namely the possibility that 
healthy non-targeted cells dies because of their proximity to targeted tumour cells, 
was evaluated being a phenomenon of particular interest for immunologists. One 
should recall that the bystander effect can derive both from heat released to nearby 
cells or because of the release of specific apoptotic/necrotic signals by dying cells 
which trigger the death mechanism of neighboring cells.20, 21 It is not the purpose of 
this thesis to investigate the importance of these mechanisms, and experiments were 
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done only to evaluate the presence of the effect. All experiments were done with a 
fixed exposure time. 
Experimental section 
 
Laser setup for photothermal experiments 
Laser irradiation of cells and hydrogels were performed with a continuous Ar+/Kr+ 
mixed gas laser (Coherent, Innova 70) at 647.1 nm. 
Hydrogel irradiation was performed using a beam with 5 mm diameter and 1.5 W 
cm-2 power density. Cells irradiation was performed using a focused beam with ca. 1 
mm diameter. The beam size have been measured by a Laser Beam Analyzer system 
(Spiricon) equipped with a CCD camera with 1600 x 1200 pixels and 4.4 "m pixel 
pitch. Power densities used in irradiations are: 38 W cm-2 for irradiation of non-
treated cells, 39 W cm-2 for irradiation of CSS-Ab loaded PSMA+ (PC3-PIP) cells 
varying time, 36 W cm-2 for irradiation of adherent cells and 39 W cm-2 for 
irradiation in bystander effect experiment.  
 
Preparation of CS and CSS nanostructures loaded agarose hydrogel 
For hydrogel preparation we used a 1% w/w aqueous solution of agarose (Sigma-
Aldrich, low EEO). The solution was heated until dissolution of agarose and then CS 
or CSS nanostructures were added to a final concentration of 20 pM. The solution 
was then cooled to allow hydrogel formation. Hydrogels were then cutted in discs 
with 1 cm diameter and 0.5 cm height and stored in dd water solution until their use. 
During laser irradiation, all hydrogels are maintained at 37°C in a home-made 
thermostatic chamber. Hydrogel temperature during irradiation is monitored every 
minute for 10 minutes using a FLIR E5 thermocamera. 
Cell culture and viability 
Cell culture were conducted as reported above in the corresponding part in the 
“Immunomagnetic sorting of cancer cells” section. Incubation and sample 
preparation depend on the experiment (see below). Cell viability is assessed with 
trypan blue assay performing the test at least 1.30 h after irradiation. 
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Irradiation of cells not incubated with CSS-Ab 
PSMA+ (PC3-PIP) cells not incubated with CSS-Ab were made to adhere to 3.5 cm 
diameter wells containing RPMI 160 culture medium. Cells were irradiated for 5.00, 
10.00 and 15.00 minutes and viability was evaluated right after irradiation (1.30 h 
after last irradiation), after 24 h and after 48 h. Every irradiation has been repeated 9 
times to obtain statistically reliable data. Viability of control samples (non irradiated 
cells) was recorded before the beginning of irradiations, right after the last 
irradiation, after 24 h and after 48 h.  
Irradiation times of PSMA+ (PC3-PIP) cells 
PSMA+ (PC3-PIP) cells were incubated with CSS-Ab nanostructures at a 
concentration of 19.1 pM, for 1h at 4°C in the presence of 5% Bovine Serum 
Albumin (BSA) to block non-specific protein interactions. After incubation time 
cells were magnetically sorted and made to adhere in 3.5 cm diameter wells 
containing RPMI culture medium. Cells were irradiated for 30 sec, 1.30 min, 3.00 
min, 5.00 min, 10.00 min and 15.00 min. Every irradiation has been repeated 6 times 
to obtain statistically reliable data. Viability of all samples has been evaluated at least 
1.30 h after irradiation. Viability of control samples (cells incubated with CSS-Ab 
but non-irradiated) has been recorded before the beginning of irradiations and after 
the last irradiation. 
Irradiation of adherent cells  
PSMA+ (PC3-PIP) cells were made to adhere in 3.5 cm diameter wells containing 
RPMI culture medium. The same was done for PSMA- (PC3) cells. CSS-Ab 
nanostructures were then diluted in the RPMI medium inside the wells to a final 
concentration of 19.1 pM. Cells in RPMI medium+CSS-Ab were then incubated at 
37°C for 30 minutes. After incubation time the liquid in the wells was removed and 
replaced with fresh culture medium. Several washes were performed to remove every 
CSS-Ab structure not bounded to cells. Irradiation on both PSMA+ and PSMA- cells 
was performed for 2.30 min, 5.00 min and 10.00 min, 6 times for every experiment. 
Viability for all samples has been evaluated at least 1.30 h after irradiation. Viability 
of control samples, consisting of PSMA+ or PSMA- cells incubated with CSS-Ab 
but non-irradiated, was recorded before the beginning of irradiations and at the end. 
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Bystander effect 
A mix of PSMA+ (PC3-PIP) and PSMA- (PC3) cells were made to adhere in 3.5 cm 
diameter wells containing RPMI culture medium and then CSS-Ab nanostructures 
were added to a final concentration of 19.1 pM. Cells were then incubated at 37°C 
for 30 minutes. After the incubation time the liquid in the wells were removed and 
replaced with fresh culture medium. Several washes were performed to remove every 
CSS-Ab structure not bounded to cells. Irradiation of cells was performed for 2.00 
min, 5.00 min and 10.00 min. The experiments were repeated 3 times for every 
experiment. Viability for all samples has been evaluated at least 1.30 h after 
irradiation. Viability of control samples, consisting of the same cells mix incubated 
with CSS-Ab but non-irradiated, was recorded before the beginning of irradiations 
and at the end. To determine the percentages of PSMA+ (PC3-PIP) and PSMA- 
(PC3) cells present in the wells, SERRS analysis of single cells was performed. The 
percentage of spectra in which crystal violet signal is found with respect to those in 
which no signal was present was assumed to be equal to the percentage of PSMA+ 
(PC3-PIP) over PSMA- (PC3) cells. Several hundreds of cells have been analyzed. 
SERRS measurements were performed directly on the wells containing culture 
medium using 633 nm laser, with 20× objective and a power of 1.54 mW. 
Results 
 
Hydrogel 
UV-Visible spectra of CS and CSS loaded hydrogels compared with those of CS and 
CSS in solution do not show remarkable differences (Figure 3.17), meaning that 
structural integrity of particles is maintained when they are included in hydrogels. 
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Figure 3.17 (A) UV-Vis spectra of aqueous solution of CS and CSS used for 
evaluation of photothermal effect. (B) UV-Vis spectra of CS and CSS loaded 
hydrogel. 
Hydrogels were irradiated with 647 nm laser line for 10 minutes recording their 
temperature every minute. Measurements are reported in figure 3.18 and show a 
rapid increase of temperature for hydrogel containing CSS nanostructures (14°C in 
the first minute) while for those containing CS the increase was only of the 4-5°C. 
Temperature of CSS loaded hydrogel was increased of about 20°C in 10 minutes of 
irradiation while those with CS increased their temperature of only 4-5°C. This 
confirms that the presence of AuNPs is essential and that photothermal effect is 
efficient. 
 
Figure 3.18 Temperature of CS (red) and CSS (blue and violet) loaded hydrogels 
irradiated for 10 minutes with a 647 nm laser line at a power density of 1.5 W cm-2.  
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In figure 3.19 thermal images of hydrogels at the beginning and at the end of laser 
irradiation are reported. 
 
Figure 3.19 Hydrogels loaded with CS and CSS (photos on the left) and thermal 
images registered at the beginning and at the end of laser irradiation. 
Irradiation of PSMA+ (PC3PIP) cells not incubated with CSS-Ab 
This experiment shows the effect of the laser source on cell viability.  
Uv-Visible spectra of the culture medium show that absorption at 647 nm was absent 
(Figure 3.20).  
Histogram in figure 3.21 shows that after 5.00, 10.00 and 15.00 minutes of 
irradiation, the viability of cells is close to 100% and comparable to that of control 
samples (non-irradiated). No effect is observed also after 24 and 48 hour from 
irradiation. These results confirm that laser light has no effect on cell viability. 
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Figure 3.20 UV-Visible spectra of RPMI colture medium used during laser 
irradiation of PSMA+ (PC3-PIP) and PSMA- (PC3) cells. Spectra show no 
absorption at 647 nm, the wavelength used in photothermal treatment of cancer cells. 
 
 
Figure 3.21 Viability of PSMA+ (PC3-PIP) cells non incubated with CSS-Ab 
nanostructures and irradiated for 5.00, 10.00 and 15.00 minutes with a 647 nm laser 
line at 38 W cm-2. Viability is evaluated right after irradiation (black bars), after 24h 
from irradiation (red bars) and after 48h (blue bars). Viability of control samples 
(non-irradiated cells, green bars) is evaluated at the beginning of experiment (Start), 
after 24h (End 1) and after 48h (End 2).  
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Effect of irradiation time on PSMA+ (PC3-PIP) cells 
Cells were magnetically sorted and made to adhere to wells in the presence of culture 
medium and then irradiated for 30 sec, 1.30, 3.00, 5.00, 10.00 and 15.00 minutes. 
Histogram in figure 3.22 shows the PSMA+ (PC3-PIP) cells viability as a function of 
irradiation time. Viability rapidly decreases within 3 minutes of irradiation and 
reaches almost 0% for cell irradiated from 5 minutes to 15 minutes. 
 
 Figure 3.22 Viability PSMA+ (PC3-PIP) cells incubated with CSS-Ab as a function 
of irradiation time with a 647 nm laser line at 39 W cm-2 (cyan bars). Control 
samples (green bars) are cells incubated but not irradiated.  
Results show great efficiency of the photothermal process on the viability of cells 
since also short irradiation times were sufficient for dramatic effect on cells viability. 
Looking at viability of control samples, one finds that treatment with CSS-Ab does 
not affect cells viability. 
Photothermal effect on adherent cell 
The difference between this experiment and the previous one is that now adherent 
cells are in the wells and CSS-Ab are inoculated directly in the culture medium. This 
procedure simulates the interaction that there would be between a tissue, whose cells 
are “static”, and CSS-Ab nanostructures that reach the tissue through extravasation. 
Clearly, in this case magnetic properties of particles were not necessary. To simulate 
better a biological environment, incubation was performed at 37°C. After incubation 
time (30 min) the liquid was removed and replaced with fresh culture medium. 
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Irradiation was performed on both PSMA+ (PC3-PIP) and PSMA- (PC3) cells for 
2.30 min, 5.00 min and 10.00 min. 
Results in figure 3.23 shows a drastic decrease of PSMA+ (PC3) cells viability only 
after 2.30 minutes of irradiation, with values falling from 95% to less than 10%. 
Viability slightly decreases as irradiation time is prolonged, reaching almost 2-3 % 
after 10 minutes of irradiation. Viability of irradiated PSMA- (PC3) cells remains 
practically unaltered and comparable with that of controls for all irradiation time. 
This, again, confirms the high targeting specificity of CSS-Ab nanostructures against 
PSMA+ cells only.  
 
Figure 3.23 Cell viability after irradiation of PSMA+ (PC3-PIP, green bars) and 
PSMA- (PC3, cyan bars) adherent cells. Both cells type are incubated with CSS-Ab 
nanostructures and irradiated for 2.30, 5.00 and 10.00 minutes with a 647 nm laser 
line at 36 W cm-2.  
 
Figure 3.24 shows two images of PSMA+ and PSMA- cells irradiated for 5 minutes. 
Thanks to trypan blue staining, one finds that cells death occurred only in sample 
containing PSMA+ cells where they are irradiated by the laser spot. 
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Figure 3.24 Two images of irradiated area taken with optical microscope. Red 
circles delimit irradiated area. As evidenced by trypan blue assay, cells death is 
present only for PSMA+ cells (left) and not for PSMA- cells (right). 
Evaluation of bystander effect 
The evaluation of the bystander effect was performed by irradiating a mix of PSMA+ 
(PC3-PIP) and PSMA- (PC3) cells. The purpose is to assess if dying cells stimulates 
apoptosis mechanism also in surrounding cells. Histogram in figure 3.25 shows that 
the viability of PSMA- cells incubated with CSS-Ab and then irradiated remains at 
high levels, comparable with those PSMA- cells that have not been irradiated. For 
this reason, when the two cell types are mixed, incubated with CSS-Ab 
nanostructures and irradiated, we expect the death of PSMA+ cells only while 
PSMA- cells should not be affected. The evaluation of the bystander effect is 
important because in a real situation tumoral cells can be close to healthy cells, so 
one has to consider the damaging of healthy cells by surrounding cancer cells 
undergoing photothermal treatment. 
Mixed cells were incubated with CSS-Ab using the same procedure used for 
adherent cells. Since it is difficult to distinguish the two cell types with a microscope 
analysis, SERRS signals were used to determine the percentage of PSMA+ (PC3-
PIP) and PSMA- (PC3) cells present in the sample, considering that only PSMA+ 
cells show these signals.  
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Histogram in figure 3.25 shows viability of mixed cells at three different irradiation 
times (2.30, 5.00 and 10.00 minutes). The red dashed line represents the percentage 
of PSMA- cells. 
 
Figure 3.25 Viability after irradiation of PSMA+ (PC3-PIP) and PSMA- (PC3) 
mixed cells (cyan bars) and non-irradiated controls (green bars). Cells type are 
incubated with CSS-Ab nanostructures and irradiated for 2.30, 5.00 and 10.00 
minutes with a 647 nm laser line at 39 W cm-2. A viability value below the 
percentage of PSMA- cells means that the presence of bystander effect is present. 
Results show that for all irradiation times viability values are below the percentage of 
PSMA- cells. This suggests that the bystander effect is present. In fact, if the system 
behaves as seen for adherent cells, only PSMA+ cells should have died and viability 
values should not have fallen below percentage of PSMA- cells. These results show 
that also PSMA- cells died during irradiation. As explained at the beginning of this 
section, the mechanism of the bystander effect in photothermal treatment is not yet 
well understood. Our preliminary study suggests that the effect exists, but more work 
is necessary to confirm and to explain its presence. 
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From core-shell-satellite to core-shell-
shell: tuning the plasmon to NIR 
In the previous section the efficiency of CSS-Ab nanostructures in photothermal 
treatment of prostatic cancer cells was shown. All experiment were performed using 
the 647 nm laser line but, recalling the dedicated section in the introduction, the use 
of a laser with a wavelenght more shifted to the NIR spectral region, would be more 
appropriate because of its deeper penetration through tissues. The LSPR of 
nanostructured materials determines which laser line has to be used to exploit the 
photothermal effect. Since CSS-Ab have their LSPR in the range 600-700 nm 
spectral range, one would like to use nanostructures with absorption more shifted in 
the NIR region. Therefore, we tried to modify the optical properties of CSS 
nanostructures acting on the external silica shell. It is known, in fact, that particles 
with a continuous gold shell on a silica shell may show LSPR in NIR region, 
depending on shell characteristics, in particular its thickness with respect to the 
nanostructure diameter. 
In this section the preliminary results on the synthesis of FeOxNPs@dye-doped 
Silica@Au core-shell-shell nanostructures are presented. 
FeOxNPs@dye-doped silica core-shell (CS) nanostructures are synthetized and gold 
seeds consisting of AuNPs with 2-3 nm radius are conjugated to silica shell surface 
thanks to the presence of –SH groups on silica shell. The last step involves reduction 
of gold ions on silica shell using sodium borohydride as reductant. 
Methods 
The synthesis of FeOxNP@dye-doped Silica core shell (CS) nanostructures proceeds 
as described in the section “Assembling of antibody functionalized core-shell-
satellite (CSS-Ab) nanostructures”. After the synthesis, CS nanostructures were 
dispersed in PBS. 
Synthesis of Au seeds 
Gold nanoparticles obtained by LASiS using the same procedure reported in chapter 
2 were fragmented using 532 nm pulsed laser (10 Hz) with a fluence of 260 mJ/cm2. 
Before performing fragmentation, TWEEN 20 (Sigma) was added to AuNPs solution 
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to a final concentration of 0.5% v/v to stabilize the fragmented nanoparticles. After 
30 minutes, fragmentation was stopped and the solution was centrifuged at 30000 g 
for 15 minutes. After centrifugation, the supernatant solution contains gold 
nanoparticles with 2-3 nm radius. Their average diameter was obtained through Mie-
Gans fitting of the UV-Visible spectra and confirmed by TEM measurements (see 
figure 3.26).  
Synthesis of CS-Seed 
Gold seeds were added to a CS nanostructures solution (100 pM) to a final 
concentration of 5$10-7 M. The solution was placed in a sonicating bath for 1h to 
promote seeds conjugation to silica shell. After sonication, CS-Seeds were purified 
from unconjugated seeds through magnetic separation. 
Synthesis of core-shell-shell nanostructures   
First a solution was prepared mixing 500 "L of HAuCl4$xH2O (0.009 M) with 2 mL 
of K2CO3 (0.011 M). The solution was then stirred for 15 minutes and then CS-Seeds 
nanostructures were added to a final concentration of 9$10-11 M. The solution was 
stirred in the dark for 24 hours (dark aging). After dark aging, 68 "L of a NaBH4 
solution (0.05 M) were slowly added to aged solution under stirring. Nanostructures 
were cleaned from reagents through magnetic separation and washing. Molar 
proportions for the reagents are HAuCl4:CS-Seed:NaBH4=1:1.2$10-9:0.8. 
Results 
TEM image of AuNPs with 2-3 nm radius conjugated to CS shell is reported in 
figure 3.27 where the seeds are observable as smaller dark spots. 
The UV-Visible spectra of these core-shell-shell nanostructures is reported in figure 
3.28 (black spectra) and compared with that of initial CS-seed nanostructures (violet 
spectra). Comparing the two spectra, one can notice a red-shift of the plasmonic band 
from 600-650 nm to 700-750 nm. This variation of LSPR position shows that 
morphological changes occurred in the structure.  
A TEM image of a representative nanostructure after the gold salt reduction is 
reported in figure 3.29. One notes that, although much more small AuNPs are 
densely packed on the surface, with respect to those observed for the CS-Seed 
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nanostructures, the formation of a continuous shell is not obtained. The presence of a 
continuous shell would have shifted the spectrum more to the NIR spectral region. 
Clearly, further efforts must be done to control the morphology of CS-Seed 
nanostructures for obtaining a better result.  
 
Figure 3.26 TEM images of AuNPs with 2-3 nm radius obtained with the 
fragmentation of gold nanoparticles with 10 nm radius. Fragmented AuNPs are used 
as seed. 
 
Figure 3.27 TEM micrograph of CS-Seed nanostructures. 
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Figure 3.28 UV-Visible-NIR spectra of CS-seed nanostructures before (violet 
spectra) and after (black spectra) the reduction of gold ions. A red-shift of the 
plasmon band from 600-650 nm to 700-750 nm is observable. 
 
Figure 3.29 TEM micrograph of CS-Seed after the reduction of gold ions. 
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Conclusion 
In this chapter the synthesis, characterization and in vitro application of magneto-
plasmonic core-shell-satellite (CSS) nanostructures made of an iron oxide core 
surrounded by a dye-doped silica shell and gold nanoparticles as satellites are 
reported.  
CSS nanostructures showed good magnetic and SERRS properties, suitable for their 
use in nanomedicine. CSS nanostructures were functionalized with D2B antibody 
(CSS-Ab), specific for the identification of the PSMA antigen, which is 
overexpressed by prostatic cancer cells. Immunomagnetic sorting efficiency of CSS-
Ab nanostructures was evaluated showing specificity, accuracy and sensitivity close 
to 100%. The possibility to perform SERRS analysis at single cell level was also 
assessed showing promising results for CSS application in multiplexed analysis.  
CSS-Ab nanostructures showed also good photothermal effect if irradiated with a 
647 nm laser and their efficiency in photothermal treatment of cancer cell was 
evaluated. First, irradiation of PSMA+ (PC3-PIP) cells incubated with CSS-Ab at 
different times was performed. Low viability was observed after only 3 minutes of 
irradiation. In a second experiment adherent cells, which simulate ‘static’ cells found 
in a tissue, were used. Also in this case the viability for PSMA+ (PC3-PIP) cells 
were found very low after only 2,30 min of irradiation whereas, thanks to the CSS-
Ab specificity, PSMA- (PC3) cells were practically unaffected.  
In the last part the presence of the bystander effect was evaluated irradiating sample 
of mixed PSMA+ and PSMA- cell. The preliminary results show that bystander 
effect is present.  
Finally, the morphological features of the CSS nanostructures were considered in 
order to tune their LSPR in the NIR region. Results show that the plasmon tuning is 
possible, but more experiments are needed to obtain a controlled shift of the 
plasmonic resonances in the NIR. 
The nanostructures presented in this chapter can be considered a theranostic agent 
because of their possible use for diagnosis, exploiting the magnetic separation and 
the SERRS effect, and for therapy using the photothermal effect. 
Future perspective for these nanostructures concerns the evaluation of their use in 
multiplexed analysis for diagnosis, and, for therapy, the use of magnetotherapy, 
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namely of the generation of heat with variable magnetic field, together with 
phototherapy. 
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Conclusion 
In the overall nanotechnology panorama, nanostructured materials are emerging as 
realistic and possible solution to problems in nanomedicine. In the introductory 
section an overview of nanostructured materials for application in nanomedicine was 
given, with particular attention for those made of gold and iron oxide due to their 
useful optical and magnetic properties and their recognized biocompatibility. 
Although some nanomaterials are already commercialized and used in medicine, the 
perspectives for their future use can be foreseen to increase greatly, given also the 
funded programs around the world.   
In this thesis, two magneto-plasmonic nanosystems for application in cancer research 
were presented. The first one consisting of gold and iron oxide aggregates and the 
second one of a core-shell-satellite type structure, with core iron oxide nanoparticles, 
a silica shell and satellite gold nanoparticles. The two nanostructures were obtained 
with nanoparticles synthesized with a green technique like the laser ablation in water. 
Clearly, these materials decrease harmful consequences that can be produced by 
reagents used in other type of nanoparticles synthesis and that can be found in the 
final products.  
Magneto-plasmonic nano-aggregates were simply assembled by controlling surface 
charges on nanoparticles and were used for cell labeling and guiding. A more 
engineered core-shell-satellite nanostructure was also obtained and found to be 
efficient both for immunomagnetic sorting and for photothermal treatment of cancer 
cells. We quantified their efficiency and found that such a nanostructures can be used 
for both diagnostic and therapy purposes, namely as theranostic agents. 
The work presented in this thesis can be considered one step closer to the use of 
highly pure nanostructured materials for diagnosis and treatment of diseases. 
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